Journal ArticleHPB (Oxford) · April 2024
BACKGROUND: Radical cholecystectomy is recommended for T1B and greater gallbladder cancer, however, there are conflicting reports on the utility of extended resection for T1B disease. Herein, we characterize outcomes following simple and radical cholecyste ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · March 2024
ABSTRACT: BACKGROUND: Pancreatic adenocarcinoma (PDAC) is highly lethal with up to 80% of resected patients experiencing disease recurrence within 2 years (Watanabe, Nakamura, Kimura et al in Int J Mol Sci 23(19):11521, 2022). Cross-sectional imaging and ...
Full textLink to itemCite
Journal ArticleAnn Surg · December 1, 2023
OBJECTIVE: To implement a machine learning model using only the restricted data available at case creation time to predict surgical case length for multiple services at different locations. BACKGROUND: The operating room is one of the most expensive resour ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Surg Oncol · December 2023
OBJECTIVES: We performed a retrospective analysis within a national cancer registry on outcomes following resection or ablation for intrahepatic cholangiocarcinoma (iCCA). METHODS: The National Cancer Database was queried for patients with clinical stage I ...
Full textLink to itemCite
Journal ArticlePM R · October 2023
BACKGROUND: Golf is a moderate-intensity physical activity that provides positive physical and mental health benefits. However, the inclusiveness of the sport for individuals with disabilities globally is unknown. OBJECTIVE: To characterize the demographic ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · October 2023
BACKGROUND: Hepatectomy is the cornerstone of curative-intent treatment for intrahepatic cholangiocarcinoma (ICC). However, in patients unable to be resected, data comparing efficacy of alternatives including thermal ablation and radiation therapy (RT) rem ...
Full textOpen AccessLink to itemCite
Journal ArticleAnn Surg · August 1, 2023
BACKGROUND AND OBJECTIVE: Robotic distal pancreatectomy (DP) is an emerging attractive approach, but its role compared with laparoscopic or open surgery remains unclear. Benchmark values are novel and objective tools for such comparisons. The aim of this s ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · August 2023
BACKGROUND: Resection remains the cornerstone of curative-intent treatment for biliary tract cancers (BTCs). However, recent randomized data also support a role for adjuvant chemotherapy (AC). This study aimed to characterize trends in the use of AC and su ...
Full textLink to itemCite
Journal ArticleSurgery · August 2023
Patients with unresectable colorectal liver metastases are commonly treated with systemic chemotherapy to convert their disease to an operable state. Unfortunately, many patients remain unresectable after first-line chemotherapy and resort to second- and t ...
Full textLink to itemCite
Journal ArticleNature · August 2023
A growing body of literature suggests that alterations in the human microbiome are causative of disease initiation and progression. Aykut et al. present data supporting the argument that alterations in the gut fungal microbiome (the “mycobiome”), along wit ...
Full textLink to itemCite
Journal ArticleAnn Surg · April 1, 2023
OBJECTIVE: To validate the 7 th and 8 th editions of the AJCC staging system for patients with invasive carcinomas arising in association with IPMN (IPMN-associated PDAC). BACKGROUND DATA: Although several studies have validated AJCC systems in patients wi ...
Full textLink to itemCite
Journal ArticleSci Adv · March 15, 2023
The histopathologic heterogeneity of intraductal papillary mucinous neoplasms (IPMN) complicates the prediction of pancreatic ductal adenocarcinoma (PDAC) risk. Intratumoral regions of pancreaticobiliary (PB), intestinal (INT), and gastric foveolar (GF) ep ...
Full textLink to itemCite
Journal ArticleCA Cancer J Clin · March 2023
Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver tumor and remains a fatal malignancy in the majority of patients. Approximately 20%-30% of patients are eligible for resection, which is considered the only potentially curative ...
Full textLink to itemCite
Journal ArticlebioRxiv · January 6, 2023
Outcomes following tumor resection vary dramatically among patients with pancreatic cancer. A challenge in defining predictive biomarkers is to discern within the complex tumor tissue the specific subpopulations and relationships that drive recurrence. Mul ...
Full textLink to itemCite
Journal ArticleFrontiers in oncology · January 2023
IntroductionOutcomes following tumor resection vary dramatically among patients with pancreatic ductal adenocarcinoma (PDAC). A challenge in defining predictive biomarkers is to discern within the complex tumor tissue the specific subpopulations a ...
Full textOpen AccessCite
Journal ArticleFront Immunol · 2023
BACKGROUND: Monocytes and monocyte-derived tumor infiltrating cells have been implicated in the immunosuppression and immune evasion associated with pancreatic adenocarcinoma (PDAC). Yet, precisely how monocytes in the periphery and tumor microenvironment ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · December 2022
BACKGROUND: Widespread implementation of HAI pump chemotherapy has been limited by logistic and feasibility concerns. Recent studies demonstrating excellent outcomes have fueled renewed enthusiasm and multiple new programs have emerged. This survey aims to ...
Full textLink to itemCite
Journal ArticleAnn Surg · December 1, 2022
BACKGROUND: Hepatic artery infusion (HAI) is a liver-directed therapy that delivers high-dose chemotherapy to the liver through the hepatic arterial system for colorectal liver metastases and intrahepatic cholangiocarcinoma. Utilization of HAI is rapidly e ...
Full textLink to itemCite
ConferenceAnn Surg Oncol · November 2022
BACKGROUND: Intraductal papillary mucinous neoplasms (IPMN) are the only radiographically identifiable precursor to pancreatic adenocarcinoma, yet little is known about how these lesions progress to cancer. Inflammation has been associated with dysplastic ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · October 2022
Resulting from 50 years of innovation, operations for pancreatic neoplasms can now be performed safely, albeit with significant but manageable morbidity. Molecular diagnosis has allowed for the identification of multiple distinct histopathologies with vari ...
Full textLink to itemCite
Journal ArticleAnnals of Surgical Oncology · August 1, 2022
Background: Liver metastasis (LM) after pancreatic ductal adenocarcinoma (PDAC) resection is common but difficult to predict and has grave prognosis. We combined preoperative clinicopathological variables and quantitative analysis of computed tomography (C ...
Full textCite
Journal ArticleAnn Surg · August 1, 2022
OBJECTIVE: Prospective evaluation of 2 clinical-molecular models in patients with unknown pathology who underwent endoscopic ultrasound with fine-needle aspiration (EUS-FNA) for a cystic lesion of the pancreas. SUMMARY OF BACKGROUND DATA: Preoperative pred ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · July 2022
BACKGROUND: Standard of care for resectable pancreatic cancer is a combination of surgical resection (SR) and multiagent chemotherapy (MCT). We aim to determine whether SR or MCT is associated with superior survival for patients receiving only single-modal ...
Full textLink to itemCite
Journal ArticleSurgery · July 2022
BACKGROUND: Drain use in pancreatic surgery remains controversial. This survey sought to evaluate habits, experiences, and opinions of experts in the field on the use of drains to provide interesting insights for pancreatic surgeons worldwide. METHODS: An ...
Full textLink to itemCite
Journal ArticleAm Surg · June 2022
BACKGROUND: Neutrophil-to-lymphocyte ratio (NLR) has been reported as prognostic in pancreatic ductal adenocarcinoma (PDAC). Data about NLR changes during neoadjuvant therapy (NAT) and its relationship with pathological tumor response and survival are lack ...
Full textLink to itemCite
ConferenceBritish Journal of Surgery · May 31, 2022
AbstractObjectiveRobotic distal pancreatectomy (DP) is emerging as the preferred treatment for body and tail tumors of the pancreas. T ...
Full textCite
Journal ArticleJ Gastrointest Surg · April 2022
BACKGROUND: Colorectal liver metastases (CRLM) are the most common cause of disease-specific mortality in patients with colorectal cancer. Hepatic artery infusion (HAI) combined with systemic chemotherapy improves survival for these patients. The safety of ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · April 1, 2022
BACKGROUND: This prospective study was designed to compare quality of life (QoL) among patients who underwent open (O-PD) vs minimally invasive pancreaticoduodenectomy (MI-PD), using a combination of validated qualitative and quantitative methodologies. ST ...
Full textLink to itemCite
Journal ArticleJournal of surgical oncology · March 2022
ObjectivesPatients with locally advanced pancreatic adenocarcinoma (PDAC) receive induction chemotherapy with or without radiation, with the goal of R0 resection and improving survival. Herein, we evaluate the outcomes of patients who presented wi ...
Full textCite
ConferenceJournal of Clinical Oncology · February 1, 2022
120 Background: Hepatic artery infusion (HAI) is a liver directed therapy to treat unresectable or resected colorectal liver metastases (CRLM) and unresectable intrahepatic cholangiocarcinoma (ICC). Historically, HAI has only bee ...
Full textCite
Journal ArticleAnn Surg · December 1, 2021
OBJECTIVE: To develop a nomogram estimating the probability of recurrence free at 5 years after resection for localized grade 1 (G1)/ grade 2 (G2) pancreatic neuroendocrine tumors (PanNETs). BACKGROUND: Among patients undergoing resection of PanNETs, appro ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · December 2021
BACKGROUND: The aim of the present study was to evaluate the impact of routine NGT decompression after PD on postoperative outcomes in the era of an enhanced recovery after surgery (ERAS) protocol. MATERIALS AND METHODS: A retrospective review of all patie ...
Full textLink to itemCite
Journal ArticleAnn Surg · December 1, 2021
OBJECTIVE: To evaluate the influence of consensus guidelines on the management of intraductal papillary mucinous neoplasms (IPMN) and the subsequent changes in pathologic outcomes. BACKGROUND: Over time, multiple guidelines have been developed to identify ...
Full textLink to itemCite
Journal ArticleHepatology · September 2021
BACKGROUND AND AIM: Genetic alterations in intrahepatic cholangiocarcinoma (iCCA) are increasingly well characterized, but their impact on outcome and prognosis remains unknown. APPROACH AND RESULTS: This bi-institutional study of patients with confirmed i ...
Full textLink to itemCite
Journal ArticleAnnals of surgical oncology · July 2021
BackgroundHepatic artery infusion (HAI) chemotherapy is associated with overall survival (OS) in patients with resected colon cancer liver metastases (CLM). The prognostic impact of primary tumor location in CLM following hepatic resection in pati ...
Full textCite
Journal ArticleAnn Surg Oncol · June 2021
BACKGROUND: Pancreatic metastases (PM) from renal cell carcinoma (RCC) are uncommon. We herein describe the long-term outcomes associated with pancreatectomy at two academic institutions, with a specific focus on 10-year survival. METHODS: This investigati ...
Full textLink to itemCite
Journal ArticleJCO Clin Cancer Inform · June 2021
PURPOSE: The therapeutic management of pancreatic neuroendocrine tumors (PanNETs) is based on pathological tumor grade assessment. A noninvasive imaging method to grade tumors would facilitate treatment selection. This study evaluated the ability of quanti ...
Full textLink to itemCite
Journal ArticleSurgery · May 2021
BACKGROUND: The role of portal vein resection for pancreatic cancer is well established but not for pancreatic neuroendocrine neoplasms. Evidence from studies providing information on long-term outcome after venous resection in pancreatic neuroendocrine ne ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · April 2021
BACKGROUND: The utility of adjuvant chemotherapy after resection of colorectal liver metastasis (CLM) in patients with rapid recurrence after adjuvant chemotherapy for their primary tumor is unclear. The aim of this study was to evaluate the oncologic bene ...
Full textLink to itemCite
Journal ArticleAbdom Radiol (NY) · April 2021
PURPOSE: To evaluate the associations between computed tomography (CT) imaging features extracted from the structured American Pancreatic Association (APA)/Society of Abdominal Radiology (SAR) template and overall survival in patients with resected pancrea ...
Full textLink to itemCite
Journal ArticleJ Cancer Prev · March 30, 2021
The Division of Cancer Prevention of the National Cancer Institute (NCI) and the Office of Disease Prevention of the National Institutes of Health co-sponsored the Translational Advances in Cancer Prevention Agent Development Meeting on August 27 to 28, 20 ...
Full textLink to itemCite
Journal ArticleCancers (Basel) · February 1, 2021
The scope of our study was to compare the predictive ability of American Joint Committee on Cancer (AJCC) 7th and 8th edition in gallbladder carcinoma (GBC) patients, investigate the effect of AJCC 8th nodal status on the survival, and identify risk factor ...
Full textLink to itemCite
Journal ArticlePancreas · February 1, 2021
OBJECTIVES: Pancreatic neuroendocrine neoplasms include well-differentiated tumors (PanNETs) and poorly differentiated carcinomas (PanNECs). Previous reports suggested a role for platinum-based therapy largely in PanNEC. We sought to investigate the role o ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · January 2021
BACKGROUND: The association between a positive surgical margin and local recurrence after resection of pancreatic adenocarcinoma (PDAC) has been reported. Assessment of the location of the a positive margin and the specific site of local recurrence has not ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · January 2021
BACKGROUND: A subset of patients have no risk factors for the development of hepatocellular carcinoma (HCC). We evaluated differences in clinical variables between patients with and without risk factors who underwent surgical resection. METHODS: A prospect ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · January 1, 2021
PURPOSE: A subset of pancreatic ductal adenocarcinomas (PDACs) is highly resistant to systemic chemotherapy, but no markers are available in clinical settings to identify this subset. We hypothesized that a glycan biomarker for PDACs called sialylated tumo ...
Full textLink to itemCite
Journal ArticleHPB : the official journal of the International Hepato Pancreato Biliary Association · December 2020
BackgroundLow central venous pressure (LCVP) anesthesia reduces blood loss during hepatic resection and historically has required a central venous catheter (CVC) for intra-operative monitoring. The aim of this study was to assess the effect of an ...
Full textCite
Journal ArticleAnn Surg Oncol · December 2020
BACKGROUND: Hepatic artery infusion (HAI) combined with systemic chemotherapy is a treatment strategy for patients with unresectable liver-only or liver-dominant colorectal liver metastases (CRLM). Although HAI has previously been performed in only a few c ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · December 2020
BACKGROUND: Controversy exists regarding the safety and feasibility of minimally invasive resection for lesions in segments 7 or 8. We compare outcomes of minimally invasive surgery (MIS) and Open parenchymal sparing liver resections at two high-volume cen ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · December 2020
BACKGROUND: Hepatic artery infusion pump (HAIP) chemotherapy is an advanced cancer therapy for primary and secondary hepatic malignancies. The risk of concurrent hepatic and/or colorectal operations with HAIP placement is unknown. Our objective was to char ...
Full textLink to itemCite
ConferenceCancer Research · November 15, 2020
AbstractA subset of pancreatic ductal adenocarcinomas (PDACs) is highly resistant to systemic chemotherapy, but no markers are available in clinical settings to identify this subset. In this study, we evalua ...
Full textCite
Journal ArticleCancer · September 1, 2020
BACKGROUND: KRAS, TP53, CDKN2A, and SMAD4 are established driver genes in pancreatic ductal adenocarcinoma (PDAC). This study was aimed at determining whether the mutational status of driver genes and those involved in DNA repair pathways are associated wi ...
Full textLink to itemCite
Journal ArticleAnn Surg · August 2020
OBJECTIVE: To investigate the impact of adjuvant hepatic artery infusion (HAI) in relation to KRAS mutational status in patients with resected colorectal cancer liver metastases (CRLM). BACKGROUND: Patients with KRAS-mutated CRLM have worse outcomes after ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · June 2020
BACKGROUND: Histopathological growth patterns (HGPs) of colorectal liver metastases (CRLM) may be an expression of biological tumour behaviour impacting the risk of positive resection margins. The current study aimed to investigate whether the non-desmopla ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · May 2020
BACKGROUND: Both minimally invasive surgery (MIS) and open approaches for distal pancreatectomy are acceptable. MIS options include total laparoscopic/robotic (TLR) and hand-assist laparoscopy (HAL). When considering safety profile and specimen quality, th ...
Full textLink to itemCite
Journal ArticleJournal of Medical Imaging · May 1, 2020
Purpose: Our paper contributes to the burgeoning field of surgical data science. Specifically, multimodal integration of relevant patient data is used to determine who should undergo a complex pancreatic resection. Intraductal papillary mucinous neoplasms ...
Full textCite
Journal ArticleEur Radiol · January 2020
OBJECTIVES: This study aims to measure the reproducibility of radiomic features in pancreatic parenchyma and ductal adenocarcinomas (PDAC) in patients who underwent consecutive contrast-enhanced computed tomography (CECT) scans. METHODS: In this IRB-approv ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · January 2020
BACKGROUND: Obesity and metabolic syndrome are associated with inflammatory hepatic parenchymal disease (HPD) and increased risk for recurrence after resection of colorectal liver metastases (CRLM). The independent impact of HPD on recurrence patterns has ...
Full textLink to itemCite
Journal ArticleJAMA Oncol · January 1, 2020
IMPORTANCE: Unresectable intrahepatic cholangiocarcinoma (IHC) carries a poor prognosis, with a median overall survival (OS) of 11 months. Hepatic arterial infusion (HAI) of high-dose chemotherapy may have potential benefit in these patients. OBJECTIVE: To ...
Full textLink to itemCite
Journal ArticleAnn Surg · January 2020
OBJECTIVE: To analyze clinical outcomes and prognostic variables of patients undergoing hepatic resection for BRAF mutant (BRAF-mut) colorectal liver metastases (CRLM). BACKGROUND: Outcomes following hepatectomy for BRAF-mut CRLM have not been well studied ...
Full textLink to itemCite
Journal ArticleCancer Discov · January 2020
TGFβ is an important tumor suppressor in pancreatic ductal adenocarcinoma (PDA), yet inactivation of TGFβ pathway components occurs in only half of PDA cases. TGFβ cooperates with oncogenic RAS signaling to trigger epithelial-to-mesenchymal transition (EMT ...
Full textLink to itemCite
ConferenceProceedings of SPIE - The International Society for Optical Engineering · January 1, 2020
This paper contributes to the burgeoning field of surgical data science. Specifically, multi-modal integration of relevant patient data is used to determine who should undergo a complex pancreatic resection. Intraductal papillary mucinous neoplasms (IPMNs) ...
Full textCite
Journal ArticleHPB (Oxford) · November 2019
BACKGROUND: The surgical approach to gallbladder cancer (GBCA) has evolved in recent years, but the impact on outcomes is unknown. This study describes differences in presentation, surgery, chemotherapy strategy, and survival for patients with GBCA over tw ...
Full textLink to itemCite
Journal ArticleAbdom Radiol (NY) · September 2019
PURPOSE: The aim of this study was to investigate the relationship between CT imaging phenotypes and genetic and biological characteristics in pancreatic ductal adenocarcinoma (PDAC). METHODS: In this retrospective study, consecutive patients between April ...
Full textLink to itemCite
Journal ArticleGastroenterology · September 2019
BACKGROUND & AIMS: Although pancreatic cystic lesions (PCLs) are frequently and incidentally detected, it is a challenge to determine their risk of malignancy. In immunohistochemical and enzyme-linked immunosorbent assay (ELISA) analyses of tissue and cyst ...
Full textLink to itemCite
Journal ArticleCancer Prev Res (Phila) · September 2019
Germline mutations in BRCA1/2 are risk factors for pancreatic ductal adenocarcinoma (PDAC). The aim of this study was to evaluate whether results of surveillance for PDAC in high risk individuals (HRI) differ between those with and without a pathogenic BRC ...
Full textLink to itemCite
Journal ArticleEur Radiol · August 2019
PURPOSE: To develop and optimize a rapid magnetic resonance imaging (MRI) screening protocol for pancreatic cancer to be performed in conjunction with breast MRI screening in breast cancer susceptibility gene (BRCA)-positive individuals. METHODS: An IRB-ap ...
Full textLink to itemCite
Journal ArticleAnn Surg · August 2019
OBJECTIVE: To use the concept of benchmarking to establish robust and standardized outcome references after pancreatico-duodenectomy (PD). BACKGROUND: Best achievable results after PD are unknown. Consequently, outcome comparisons among different cohorts, ...
Full textLink to itemCite
Journal ArticleSci Transl Med · July 17, 2019
Pancreatic cysts are common and often pose a management dilemma, because some cysts are precancerous, whereas others have little risk of developing into invasive cancers. We used supervised machine learning techniques to develop a comprehensive test, CompC ...
Full textLink to itemCite
Journal ArticlePancreas · July 2019
OBJECTIVES: Preoperative determination of the grade of dysplasia in intraductal papillary mucinous neoplasms (IPMNs) is necessary for optimal management. Previous data have suggested that serum neutrophil-to-lymphocyte ratio (NLR) can predict invasive dise ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · June 2019
BACKGROUND: Liver resection can be curative for well-selected metastatic colorectal cancer (CRC) patients. Circulating tumor DNA (ctDNA) has shown promise as a biomarker for tumor dynamics and recurrence following CRC resection. This prospective pilot stud ...
Full textLink to itemCite
Journal ArticleUpdates Surg · June 2019
Intraductal papillary mucinous neoplasms (IPMN) of the pancreas are premalignant mucin-producing epithelial tumors that arise from the pancreatic ductal system. These cystic tumors represent 15-30% of cystic lesions of the pancreas [Basturk et al. in Am J ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · May 2019
BACKGROUND: Serum Chromogranin A (CgA) is widely used as a biomarker for pancreatic neuroendocrine tumors (PanNETs). The aim of this study was to investigate the value of CgA as a diagnostic and prognostic marker for well-differentiated PanNETs. METHODS: P ...
Full textLink to itemCite
Journal ArticleAm J Surg Pathol · May 2019
BACKGROUND: Intraductal oncocytic papillary neoplasm (IOPN) of the pancreas is a rare tumor. Recent molecular data indicate that it is distinct from other intraductal neoplasms; however, its clinicopathologic characteristics, especially the frequency/signi ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · April 2019
BACKGROUND: Post-operative peripancreatic fluid collection (PFC) is a common complication following pancreatic resection which can be managed with endoscopic or percutaneous drainage. METHODS: Patients who underwent either endoscopic or percutaneous draina ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · April 2019
BACKGROUND: Pancreaticoduodenectomy is historically associated with incisional surgical site infection (iSSI) rates between 15% and 20%. Prospective studies have been mixed with respect to the benefit of individual interventions directed at decreasing iSSI ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · April 2019
BACKGROUND: Colorectal liver metastases that demonstrate a complete radiographic response during chemotherapy are increasingly common with advances in chemotherapy regimens and are described as disappearing liver metastases (DLMs). However, these DLMs ofte ...
Full textLink to itemCite
Journal ArticleCancer · February 15, 2019
BACKGROUND: Although rare in the United States, gallbladder cancer (GBCA) is a common cause of cancer death in some parts of the world. To investigate regional differences in pathogenesis and outcomes for GBCA, tumor mutations were analyzed from a sampling ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · February 2019
BACKGROUND: Intraductal papillary mucinous neoplasms (IPMNs) are radiographically identifiable potential precursor lesions of pancreatic adenocarcinoma. While resection is recommended when main duct dilation is present, management of branch duct IPMN (BD-I ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · February 2019
BACKGROUND: Surgical site infections (SSIs) are a major cause of morbidity, mortality, and healthcare costs, and patients undergoing simultaneous colorectal/liver resections are at an especially high SSI risk. METHODS: Data were collected on all patients u ...
Full textLink to itemCite
Journal ArticleWorld J Surg · February 2019
BACKGROUND: Organ-specific complications (OSC) remain serious potential sequela of gastrointestinal surgery. Hypophosphatemia correlates with poor outcomes and may be a harbinger of OSC after gastrointestinal surgery. Our goal was to describe and evaluate ...
Full textLink to itemCite
Journal ArticleWorld J Surg · February 2019
In the original version of this article, Martin R. Weiser's last name was spelled incorrectly. It is correct as reflected here. The original article has been updated. ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · February 2019
BACKGROUND: Morbidity after pancreatectomy is commonly due to leakage of exocrine secretions resulting in abscess or pancreatic fistula (PF). Previously, we authored a double-blind randomized controlled trial demonstrating that perioperative pasireotide ad ...
Full textLink to itemCite
Journal ArticleEur Radiol · January 2019
OBJECTIVES: This study investigates whether quantitative image analysis of pretreatment CT scans can predict volumetric response to chemotherapy for patients with colorectal liver metastases (CRLM). METHODS: Patients treated with chemotherapy for CRLM (hep ...
Full textLink to itemCite
Journal ArticleMed Phys · November 2018
PURPOSE: Intraductal papillary mucinous neoplasms (IPMNs) are radiographically visible precursor lesions of pancreatic cancer. Despite standard criteria for assessing risk, only 18% of cysts are malignant at resection. Thus, a large number of patients unde ...
Full textLink to itemCite
Journal ArticleJ Natl Cancer Inst · October 1, 2018
BACKGROUND: Identification of pathogenic germline alterations (PGAs) has important clinical and therapeutic implications in pancreas cancer. We performed comprehensive germline testing (GT) in an unselected prospective cohort of patients with exocrine panc ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · September 2018
BACKGROUND: Patients with resectable perihilar cholangiocarcinoma (PHC) on imaging have a substantial risk of metastatic or locally advanced disease, incomplete (R1) resection, and 90-day mortality. Our aim was to develop a preoperative prognostic model to ...
Full textLink to itemCite
Journal ArticleCancer Discov · September 2018
Pancreatic cancer is the most lethal common solid malignancy. Systemic therapies are often ineffective, and predictive biomarkers to guide treatment are urgently needed. We generated a pancreatic cancer patient-derived organoid (PDO) library that recapitul ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · August 2018
BACKGROUND: Many patients with resectable perihilar cholangiocarcinoma (PHC) on imaging are diagnosed intraoperatively with occult metastatic or locally advanced disease, precluding a curative-intent resection. This study aimed to develop and validate a pr ...
Full textLink to itemCite
Journal ArticleBr J Surg · August 2018
BACKGROUND: This study sought to develop a clinical risk score for resectable colorectal liver metastasis (CRLM) by combining clinicopathological and clinically available biological indicators, including KRAS. METHODS: A cohort of patients who underwent re ...
Full textLink to itemCite
Journal ArticleAbdom Radiol (NY) · August 2018
PURPOSE: Clinician gestalt may hold unexplored information that can be capitalized upon to improve existing nomograms. The study objective was to evaluate physician ability to predict 2-year overall survival (OS) in resected pancreatic ductal adenocarcinom ...
Full textLink to itemCite
Journal ArticleAnn Surg · August 2018
OBJECTIVE: Preliminary work by our group suggested that proteins within the pancreatic cyst fluid (CF) may discriminate degree of IPMN dysplasia. We sought to externally validate these markers and determine whether their inclusion in a preoperative clinica ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · July 2018
BACKGROUND: Exosomes are nanovesicles that have been shown to mediate carcinogenesis in pancreatic ductal adenocarcinoma (PDAC). Given the direct communication of pancreatic duct fluid with the tumor and its relative accessibility, we aimed to determine th ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · June 2018
BACKGROUND: Although IPMN are thought to represent a whole-gland disease, segmental resection remains the most frequently performed treatment. We sought to determine the rates, patterns, and predictors of IPMN progression in the pancreatic remnant followin ...
Full textLink to itemCite
Journal ArticleClin Colorectal Cancer · June 2018
PURPOSE: To assess clinical characteristics of patients with metastatic pancreas ductal adenocarcinoma (PDAC) and brain metastases (BM), and to assess somatic and germ-line molecular profiles where performed. PATIENTS AND METHODS: Patients with PDAC and BM ...
Full textLink to itemCite
Journal ArticleSurgery · June 2018
BACKGROUND: Hepatic resection of colorectal liver metastases is associated with long-term survival. This study analyzes actual 10-year survivors after resection of colorectal liver metastases, reports the observed rate of cure, and identifies factors that ...
Full textLink to itemCite
Journal ArticleGut · May 2018
Evidence-based guidelines on the management of pancreatic cystic neoplasms (PCN) are lacking. This guideline is a joint initiative of the European Study Group on Cystic Tumours of the Pancreas, United European Gastroenterology, European Pancreatic Club, Eu ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · May 2018
BACKGROUND: Post-hepatectomy liver insufficiency (PHLI) is a significant cause of morbidity and mortality after liver resection. Quantitative imaging analysis using CT scans measures variations in pixel intensity related to perfusion. A preliminary study d ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · April 2018
BACKGROUND: Pancreatic cancer is a highly lethal cancer with no established a priori markers of survival. Existing nomograms rely mainly on post-resection data and are of limited utility in directing surgical management. This study investigated the use of ...
Full textLink to itemCite
Journal ArticleCancers · March 7, 2018
Approximately 75% of patients with pancreatic ductal adenocarcinoma are diagnosed with advanced cancer, which cannot be safely resected. The most commonly used biomarker CA19-9 has inadequate sensitivity and specificity for early detection, which we define ...
Full textCite
Journal ArticleJ Surg Oncol · March 2018
BACKGROUND/OBJECTIVES: Combination hepatic artery infusion (HAI) and systemic (SYS) chemotherapy for unresectable CRLM results in high tumor-response rates. This study represents an update of long-term survival and conversion to resectability in patients w ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · March 2018
BACKGROUND: Neoadjuvant treatment of colorectal liver metastases has become increasingly common, and while effective, often renders small metastases difficult to visualize on intraoperative US. The objective of this study was to determine the utility of a ...
Full textLink to itemCite
Journal ArticleScience · February 23, 2018
Earlier detection is key to reducing cancer deaths. Here, we describe a blood test that can detect eight common cancer types through assessment of the levels of circulating proteins and mutations in cell-free DNA. We applied this test, called CancerSEEK, t ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · February 2018
BACKGROUND: The impact of primary tumor location on overall survival (OS), recurrence-free survival (RFS), and long-term outcomes has not been well established in patients undergoing potentially curative resection of colorectal liver metastases (CRLM). MET ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · February 2018
AIM: The aim of this paper is to describe the characteristics of intraductal papillary mucinous neoplasms (IPMNs) of the pancreas in young patients. METHODS: We evaluated 1693 patients from the Pancreatic Surgery Consortium who underwent resection for IPMN ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · February 2018
BACKGROUND: Elevation in the serum immunoglobulin-G4 (IgG4) level has been used as a diagnostic marker to distinguish autoimmune pancreatitis (AIP) from pancreatic ductal adenocarcinoma (PDAC), but its true utility is ill-defined. This study evaluates the ...
Full textLink to itemCite
Journal ArticlePLoS One · 2018
BACKGROUND: Hepatocellular adenomas (HCA) are benign liver tumors that may transform into hepatocellular carcinoma (HCC), but the molecular drivers of this transformation remain ill-defined. This study evaluates the molecular changes in HCA and HCC and in ...
Full textLink to itemCite
ConferenceProgress in Biomedical Optics and Imaging - Proceedings of SPIE · January 1, 2018
Pancreatic neuroendocrine tumors (PanNETs) account for approximately 5% of all pancreatic tumors, affecting one individual per million each year.1 PanNETs are difficult to treat due to biological variability from benign to highly malignant, indolent to ver ...
Full textCite
Journal ArticleAnn Surg · January 2018
OBJECTIVE: Previous nomogram models for patients undergoing resection of intraductal papillary mucinous neoplasms (IPMNs) have been relatively small single-institutional series. Our objective was to improve upon these studies by developing and independentl ...
Full textLink to itemCite
Journal ArticleMod Pathol · December 2017
Intraductal tubulopapillary neoplasm is a relatively recently described member of the pancreatic intraductal neoplasm family. The more common member of this family, intraductal papillary mucinous neoplasm, often carries genetic alterations typical of pancr ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · December 2017
BACKGROUND: Microvascular invasion (MVI) is a significant risk factor for early recurrence after resection or transplantation for hepatocellular carcinoma (HCC). Knowledge of MVI status would help guide treatment recommendations, but is generally identifie ...
Full textLink to itemCite
Journal ArticleChin Clin Oncol · December 2017
Cystic lesions of the pancreas are radiographic findings that have a very broad histologic differential. This differential spans the spectrum from benign to cancerous, and includes non-neoplastic pseudocysts, benign neoplastic cysts, pre-malignant cysts, a ...
Full textLink to itemCite
Journal ArticleNature · November 23, 2017
Pancreatic ductal adenocarcinoma is a lethal cancer with fewer than 7% of patients surviving past 5 years. T-cell immunity has been linked to the exceptional outcome of the few long-term survivors, yet the relevant antigens remain unknown. Here we use gene ...
Full textLink to itemCite
Journal ArticleJ Am Coll Radiol · November 2017
Pancreatic adenocarcinoma is associated with poor overall prognosis. Complete surgical resection is the only possible option for cure. As such, increasingly complex surgical techniques including sophisticated vascular reconstruction are being used. Continu ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · November 2017
BACKGROUND: Preoperative serum inflammatory markers have been correlated with outcome after resection of hepatocellular carcinoma (HCC), but studies have had conflicting results. This study aimed to evaluate the association of six inflammatory markers with ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · October 15, 2017
Purpose: Molecular profiling in cancer has identified potential actionable drug targets that have prompted attempts to discover clinically validated biomarkers to guide therapeutic decision-making and enrollment to clinical trials. We evaluated whether com ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · October 2017
BACKGROUND: Postoperative hypophosphatemia is common and is associated with a lower risk of liver failure after hepatectomy, but higher morbidity after pancreatectomy. Whether different physiologic mechanisms underlie the hypophosphatemia associated with t ...
Full textLink to itemCite
ConferenceAnn Surg · October 2017
OBJECTIVE: This study aims to validate a previously reported recurrence clinical risk score (CRS). SUMMARY OF BACKGROUND DATA: Salvage transplantation after hepatocellular carcinoma (HCC) resection is limited to patients who recur within Milan criteria (MC ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · October 2017
OBJECTIVE: The aim of this study was to evaluate the outcome of patients presumed to have mucinous cysts of the pancreas who were initially selected for radiographic surveillance. METHODS: Patients with a pancreatic cyst and a measured cyst fluid carcinoem ...
Full textLink to itemCite
Journal ArticleProc Natl Acad Sci U S A · September 19, 2017
The earlier diagnosis of cancer is one of the keys to reducing cancer deaths in the future. Here we describe our efforts to develop a noninvasive blood test for the detection of pancreatic ductal adenocarcinoma. We combined blood tests for KRAS gene mutati ...
Full textLink to itemCite
Journal ArticleCancer Causes Control · September 2017
PURPOSE: Poor oral health appears to be a risk factor for pancreatic cancer, possibly implicating the oral microbiota. In this pilot study, we evaluated the characteristics of the oral microbiota in patients with pancreatic ductal adenocarcinoma (PDAC), in ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · September 2017
BACKGROUND: Major liver resection for perihilar cholangiocarcinoma (PHC) is associated with a 22% to 33% postoperative liver failure incidence. The aim of this study was analyze the predictive value of future liver remnant (FLR) volume for postoperative li ...
Full textLink to itemCite
Journal ArticleAnn Surg · September 2017
OBJECTIVE: In 2015, the American Gastroenterological Association recommended the discontinuation of radiographic surveillance after 5 years for patients with stable pancreatic cysts. The current study evaluated the yield of continued surveillance of pancre ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · September 2017
BACKGROUND: Recurrence after resection of colorectal liver metastases (CRLMs) occurs in up to 75% of patients. Preoperative prediction of hepatic recurrence may inform therapeutic strategies at the time of initial resection. Texture analysis (TA) is an est ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · August 2017
INTRODUCTION: Re-operation is advised for patients with T1b or greater incidental gallbladder cancer (GBCA). The presence of residual disease (RD) impacts resectability, chemotherapy, and survival. This study created a preoperative model to predict RD at r ...
Full textLink to itemCite
Journal ArticlePancreas · July 2017
OBJECTIVES: Alkylating agents have activity in well-differentiated pancreatic neuroendocrine tumors (WD panNETs). In glioblastoma multiforme, decreased activity of O-methylguanine DNA methyltransferase (MGMT) predicts response; in panNETs, MGMT relevance i ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · July 2017
BACKGROUND: Tumor-associated macrophages (TAMs) support growth in most human cancers, with the notable exception of colorectal adenocarcinoma, in which TAM infiltration of primary tumors is correlated with a better outcome. The importance of TAMs in colore ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · June 10, 2017
Purpose To investigate whether perioperative hepatic arterial infusion pump chemotherapy (HAI) was associated with overall survival (OS) in patients who had a complete resection of colorectal liver metastases (CLM). Methods Patients who underwent a complet ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · May 2017
BACKGROUND: Irreversible electroporation (IRE) has emerged as a novel, safe ablative therapy for peri-vascular lesions. However, there remains a paucity of data on long-term outcomes. METHODS: We identified patients who underwent open IRE (1/2011-6/2015) f ...
Full textLink to itemCite
ConferenceJ Am Coll Surg · May 2017
BACKGROUND: Preoperative chemotherapy is a strategy for converting to resection and/or assessing disease biology before operation. The utility of such an approach in gallbladder carcinoma (GBCA) is unknown. This study evaluated outcomes of GBCA patients tr ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · May 2017
BACKGROUND: Positive peritoneal cytology is classified as M1 disease in gastric and pancreatic cancer. While peritoneal cytology is typically obtained by laparoscopic peritoneal lavage, this study sought to examine the feasibility and safety of performing ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · May 2017
BACKGROUND: Resection of hepatocellular carcinoma (HCC) offers a chance of cure, but recurrence is common and survival is often limited. The clinical and pathological characteristics of long-term survivors have not been well studied. METHODS: We retrospect ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · March 2017
BACKGROUND: Patients and providers are increasingly interested in the utilization, safety, and efficacy of minimally invasive surgery (MIS). We reviewed 11 years of MIS resections (laparoscopic and robotic) for intra-abdominal malignancies. METHODS: Patien ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · March 2017
BACKGROUND: The first International conference on Minimally Invasive Pancreas Resection was arranged in conjunction with the annual meeting of the International Hepato-Pancreato-Biliary Association (IHPBA), in Sao Paulo, Brazil on April 19th 2016. The pres ...
Full textLink to itemCite
Journal ArticleSurgery · March 2017
BACKGROUND: In 2005, the International Study Group of Pancreatic Fistula developed a definition and grading of postoperative pancreatic fistula that has been accepted universally. Eleven years later, because postoperative pancreatic fistula remains one of ...
Full textLink to itemCite
Journal ArticleAm J Surg Pathol · March 2017
Intraductal tubulopapillary neoplasm (ITPN) is a relatively recently described member of the pancreatic intraductal neoplasm family. Thus, the literature on its histologic and immunohistochemical features, clinical behavior, and its similarities and differ ...
Full textLink to itemCite
Journal ArticleActa Oncol · March 2017
BACKGROUND: To assess local control, survival and conversion to resectability among locally advanced pancreatic cancer (LAPC) patients treated with induction chemotherapy (ICT) followed by chemoradiotherapy treatment using intensity-modulated radiation the ...
Full textLink to itemCite
Journal ArticlePancreas · March 2017
OBJECTIVES: Emerging data suggest that not all grade 3 (G3) pancreatic neuroendocrine neoplasms (panNENs) behave the same; tumor differentiation may predict outcome. METHODS: Patients with G3 panNENs treated at our institution between 1999 and 2014 were id ...
Full textLink to itemCite
Journal ArticleCancer · February 15, 2017
BACKGROUND: In the past 3 decades, a better understanding of gene mutations and their role in carcinogenesis has led to improvement in our ability to treat patients with metastatic disease. The objective of the current study was to determine whether the lo ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · February 2017
BACKGROUND: Clinical outcomes of octogenarians undergoing hepatectomy for colorectal liver metastases (CRLM) are poorly characterized. The current study evaluated operative morbidity, mortality and survival outcomes among a contemporary cohort of octogenar ...
Full textLink to itemCite
Journal ArticlePLoS One · 2017
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers in the United States with a five-year survival rate of 7.2% for all stages. Although surgical resection is the only curative treatment, currently we are unable to differentiate betwe ...
Full textLink to itemCite
ConferenceProgress in Biomedical Optics and Imaging - Proceedings of SPIE · January 1, 2017
Pancreatic cancer is the most lethal cancer with an overall 5-year survival rate of 7%1 due to the late stage at diagnosis and the ineffectiveness of current therapeutic strategies. Given the poor prognosis, early detection at a pre-cancerous stage is the ...
Full textCite
Journal ArticleAnn Surg Oncol · January 2017
BACKGROUND: The surgical management of duodenal gastrointestinal stromal tumors (DGIST) is poorly characterized. Limited resection may be technically feasible and oncologically safe, but anatomic considerations may compromise the resection margins due to t ...
Full textLink to itemCite
Journal ArticleAnn Surg · January 2017
OBJECTIVE: The objective of this study was to determine the costs of clinically significant postoperative pancreatic fistula (POPF) and to evaluate the cost-effectiveness of routine pasireotide use. SUMMARY OF BACKGROUND DATA: We recently completed a prosp ...
Full textLink to itemCite
Journal ArticleAnn Surg · January 2017
OBJECTIVE: The aim of this study was to evaluate and validate the proposed 8th edition American Joint Committee on Cancer (AJCC) system for T and N staging of pancreatic adenocarcinoma. SUMMARY OF BACKGROUND DATA: Investigators have questioned the clinical ...
Full textLink to itemCite
Journal ArticleAnn Surg · January 2017
OBJECTIVE: The aim of the study was to evaluate outcomes after resection of colorectal liver metastases (CRLM) and concurrent extrahepatic disease (EHD), and to define prognostic factors. BACKGROUND: There is increasing evidence to support resection of liv ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · October 15, 2016
Pancreatic intraductal papillary mucinous neoplasms (IPMN) are surgically treatable cancer precursors, if high-risk features can be identified. Analysis of proteins and genes in cyst fluid helps diagnostically, but prior biomarkers had limited ability to d ...
Full textLink to itemCite
ConferenceAnn Surg · October 2016
OBJECTIVE: The aim of this study is to examine, by a prospective randomized controlled trial, the influence of liberal (LIB) vs restricted (RES) perioperative fluid administration on morbidity following pancreatectomy. SUMMARY OF BACKGROUND DATA: Randomize ...
Full textLink to itemCite
Journal ArticlePLoS ONE · September 1, 2016
Background: MicroRNAs (miRNAs) are potential biomarkers in various malignancies. We aim to characterize miRNA expression in intrahepatic cholangiocarcinoma (ICC) and identify circulating plasma miRNAs with potential diagnostic and prognostic utility. Metho ...
Full textCite
ConferencePancreas · September 2016
Pancreatic cancer is the fourth leading cause of cancer related deaths in the United States with a 5-year survival rate of less than 10%. The Division of Cancer Prevention of the National Cancer Institute sponsored the Pancreatic Cancer Chemoprevention Tra ...
Full textLink to itemCite
ConferenceJ Am Coll Surg · September 2016
BACKGROUND: Liver resection is the most effective treatment for intrahepatic cholangiocarcinoma. Recurrent disease is frequent; however, recurrence patterns are ill-defined and prognostic models are lacking. STUDY DESIGN: A primary cohort of 189 patients w ...
Full textLink to itemCite
ConferenceMod Pathol · September 2016
In 2010, the World Health Organization reclassified the entity originally described as intraductal oncocytic papillary neoplasm as the 'oncocytic subtype' of intraductal papillary mucinous neoplasm. Although several key molecular alterations of other intra ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · August 1, 2016
PURPOSE: To provide evidence-based recommendations to oncologists and others for treatment of patients with locally advanced, unresectable pancreatic cancer. METHODS: American Society of Clinical Oncology convened an Expert Panel of medical oncology, radia ...
Full textLink to itemCite
Journal ArticleJournal of Gastrointestinal Oncology · August 1, 2016
Background: Early metabolic response on 18-fluorodeoxyglucose-positron emission tomography (FDG-PET) during neoadjuvant chemotherapy is PET non-responders have poor outcomes whether continuing chemotherapy or proceeding directly to surgery. Use of PET may ...
Full textCite
ConferenceJ Am Coll Surg · August 2016
BACKGROUND: Liver surgery for perihilar cholangiocarcinoma (PHC) is associated with postoperative mortality ranging from 5% to 18%. The aim of this study was to develop a preoperative risk score for postoperative mortality after liver resection for PHC, an ...
Full textLink to itemCite
Journal ArticlePancreas · August 2016
OBJECTIVES: We aimed to determine the severity and co-occurrence of established and potential paraneoplastic conditions in pancreatic cancer (weight loss, new onset diabetes, fatigue, and depression) and their relation to patient characteristics. METHODS: ...
Full textLink to itemCite
Journal ArticleSurgery · July 2016
BACKGROUND: Twenty-five percent of patients with colorectal cancer present with simultaneous liver metastasis. Complete resection is the only potential curative treatment. Due to improvements in operative and perioperative management, simultaneous liver an ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · July 2016
BACKGROUND: A recent prospective randomized trial demonstrated that prophylactic pasireotide reduces the incidence of pancreatic complications (PC) after resection. This secondary analysis aimed to describe quality of life (QoL) before and after resection, ...
Full textLink to itemCite
Journal ArticleAnn Surg · July 2016
OBJECTIVE: To evaluate the efficacy of surgical treatment for patients with isolated breast cancer liver metastases (BCLM). BACKGROUND: Single-arm retrospective studies have shown promising results associated with surgery for isolated BCLM; however, this t ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · June 10, 2016
PURPOSE: Transarterial chemoembolization is accepted therapy for hepatocellular carcinoma (HCC). No randomized trial has demonstrated superiority of chemoembolization compared with embolization, and the role of chemotherapy remains unclear. This randomized ...
Full textLink to itemCite
Journal ArticleGastrointest Endosc · June 2016
BACKGROUND AND AIMS: No reliable cyst fluid biomarkers exist that allow preoperative identification of patients with intraductal papillary mucinous neoplasms (IPMNs) and high-risk pathology. High-mobility group (HMG) A2 protein has been demonstrated to be ...
Full textLink to itemCite
Journal ArticleWorld J Surg · June 2016
BACKGROUND: In recent years, increasingly sophisticated tools have allowed for more complex robotic surgery. Robotic hepatectomy, however, is still in its infancy. Our goals were to examine the adoption of robotic hepatectomy and to compare outcomes betwee ...
Full textLink to itemCite
Journal ArticleLancet Oncol · June 2016
BACKGROUND: 35% of patients with pancreatic cancer have unresectable locally advanced disease at diagnosis. Several studies have examined systemic chemotherapy with FOLFIRINOX (leucovorin and fluorouracil plus irinotecan and oxaliplatin) in patients with l ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · May 15, 2016
PURPOSE: Risk stratification after surgery for colorectal cancer liver metastases (CRLM) is achieved using clinicopathologic variables, however, is of limited accuracy. We sought to derive and externally validate a multigene expression assay prognostic of ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · May 2016
BACKGROUND: Current preoperative risk stratification modalities for pancreatic ductal adenocarcinoma (PDA) patients are inadequate. Elevated serum matrix metalloproteinase 7 (MMP7) is associated with metastatic PDA. We evaluated preoperative MMP7 level as ...
Full textLink to itemCite
Journal ArticleEBioMedicine · May 2016
INTRODUCTION: Patients with peritoneal dissemination of pancreatic adenocarcinoma do not benefit from surgical resection, but radiologic and cytologic detection of peritoneal cancer lack sensitivity. This trial sought to determine if an oncolytic virus may ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · May 2016
BACKGROUND: Resection of colorectal liver metastases (CRLM) is associated with improved survival; however, the impact of time to resection on survival is unknown. The current multi-institutional study sought to evaluate the influence of time from diagnosis ...
Full textLink to itemCite
Journal ArticleAnn Surg · April 2016
BACKGROUND: Early invasive carcinoma may be encountered in association with intraductal papillary mucinous neoplasms (IPMNs) of the pancreas. The natural history of these early invasive lesions is unknown. METHODS: Pancreatic surgical databases from 4 high ...
Full textLink to itemCite
Journal ArticleSurg Oncol Clin N Am · April 2016
Management of cystic neoplasms of the pancreas is challenging as it relies on radiologic and cyst fluid markers to discriminate between benign and pre-cancerous lesions, however their ability to predict malignancy is limited. While asymptomatic serous cyst ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · April 2016
BACKGROUND AND OBJECTIVES: Patients who undergo liver resection for metastatic colorectal cancer (mCRC) have reported 5-year survivals ranging from 25% to 50%. The current study updated long-term survival for patients with resected liver metastases treated ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · April 2016
BACKGROUND: Improvements in liver surgery have led to decreased mortality rates. Symptomatic perihepatic collections (SPHCs) requiring percutaneous drainage remain a significant source of morbidity. STUDY DESIGN: A single institution's prospectively mainta ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · April 2016
OBJECTIVE: To analyze the natural history of small asymptomatic pancreatic neuroendocrine tumors (PanNET) and to present a matched comparison between groups who underwent either initial observation or resection. Management approach for small PanNET is unce ...
Full textLink to itemCite
Journal ArticleCancer · March 1, 2016
BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is associated with poor survival. This study compared the outcomes of patients with unresectable ICC treated with hepatic arterial infusion (HAI) plus systemic chemotherapy (SYS) with the outcomes of patien ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · February 15, 2016
PURPOSE: Most well-differentiated neuroendocrine tumors (WD-NET) of the enteropancreatic system are low-intermediate grade (G1, G2). Elevated proliferation demonstrated by either a brisk mitotic rate (>20/10 high power fields) or high Ki-67 index (>20%) de ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · February 2016
INTRODUCTION: Pancreaticoduodenectomy (PD) performed for pancreatic ductal adenocarcinoma (PDA) has a postoperative morbidity of 40-50%. In this study, we analyzed the impact of high grade complications after PD for PDA on overall survival. METHODS: A tota ...
Full textLink to itemCite
Journal ArticlePLoS One · 2016
Molecular indicators to specify the risk posed by a pancreatic cyst would benefit patients. Previously we showed that most cancer-precursor cysts, termed mucinous cysts, produce abnormal glycoforms of the proteins MUC5AC and endorepellin. Here we sought to ...
Full textLink to itemCite
Journal ArticleClin Imaging · 2016
PURPOSE: This study aims to compare tubular pancreatic ductal adenocarcinoma (tPDAC) and colloid subtype pancreatic ductal adenocarcinoma (cPDAC) associated with intraductal papillary mucinous neoplasms (IPMNs) on computed tomography. METHODS: An instituti ...
Full textLink to itemCite
ConferenceProgress in Biomedical Optics and Imaging - Proceedings of SPIE · January 1, 2016
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related death in the United States. The five-year survival rate for all stages is approximately 6%, and approximately 2% when presenting with distant disease.1 Only 10-20% of all ...
Full textCite
Journal ArticlePLoS One · 2016
OBJECTIVE: The aim of the present study is to determine if CEACAM6 can be detected in the bile of patients with biliary cancer and can serve as a diagnostic biomarker for cholangiocarcinoma. SUMMARY BACKGROUND DATA: Distinguishing bile duct carcinoma from ...
Full textLink to itemCite
Journal ArticlePract Radiat Oncol · 2016
PURPOSE: We compared gastrointestinal (GI) and hematologic toxicity in patients with locally advanced pancreas cancer (LAPC) undergoing definitive chemoradiation using intensity modulated radiation therapy (IMRT) or 3-dimensional conformal radiation therap ...
Full textLink to itemCite
Journal ArticleAnnu Rev Med · 2016
Cystic neoplasms of the pancreas are being identified at an increasing frequency largely due to the increased use of abdominal cross-sectional imaging. These neoplasms represent a heterogeneous group of tumors with various genetic alterations, molecular fe ...
Full textLink to itemCite
Journal ArticleAnn Surg · January 2016
BACKGROUND: There are no established guidelines for pathologic diagnosis/reporting of intraductal papillary mucinous neoplasms (IPMNs). DESIGN: An international multidisciplinary group, brought together by the Verona Pancreas Group in Italy-2013, was taske ...
Full textLink to itemCite
Journal ArticleLancet · December 5, 2015
BACKGROUND: The Global Burden of Disease, Injuries, and Risk Factor study 2013 (GBD 2013) is the first of a series of annual updates of the GBD. Risk factor quantification, particularly of modifiable risk factors, can help to identify emerging threats to p ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · December 2015
BACKGROUND: Endoscopic biliary drainage (EBD) and percutaneous transhepatic biliary drainage (PTBD) are both used to resolve jaundice before surgery for perihilar cholangiocarcinoma (PHC). PTBD has been associated with seeding metastases. The aim of this s ...
Full textLink to itemCite
ConferenceJ Am Coll Surg · December 2015
BACKGROUND: The aim of this study was to investigate the rate and pattern of recurrence after curative intent resection of perihilar cholangiocarcinoma (PHC). STUDY DESIGN: Patients were included from 2 prospectively maintained databases. Recurrences were ...
Full textLink to itemCite
ConferenceAnn Surg · December 2015
OBJECTIVES: To evaluate the association of tumor-associated neutrophils (TANs) with malignant progression in intraductal papillary mucinous neoplasms (IPMNs) and to study the cyst fluid from these lesions for biomarkers of the inflammation-carcinogenesis a ...
Full textLink to itemCite
ConferenceHPB (Oxford) · December 2015
BACKGROUND: Mortality after major hepatectomy remains high and is frequently related to post-hepatectomy liver failure (PHLF). Other than pre-existing liver disease and a small future liver remnant, few patient factors or early postoperative indicators ide ...
Full textLink to itemCite
Journal ArticleEndoscopy · December 2015
BACKGROUND AND STUDY AIMS: Preoperative biliary drainage is often initiated with endoscopic retrograde cholangiopancreatography (ERCP) in patients with potentially resectable perihilar cholangiocarcinoma (PHC), but additional percutaneous transhepatic cath ...
Full textLink to itemCite
Journal ArticleGastroenterology · November 2015
BACKGROUND & AIMS: The management of pancreatic cysts poses challenges to both patients and their physicians. We investigated whether a combination of molecular markers and clinical information could improve the classification of pancreatic cysts and manag ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · November 2015
OBJECTIVE: The aim of this study is to determine the prevalence of diabetes mellitus (DM) in patients with intraductal papillary mucinous neoplasm of the pancreas (IPMN) and compare rates of new/progressive DM between IPMN patients undergoing pancreatectom ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · November 2015
OBJECTIVE: To compare surgical outcomes between matched central hepatectomy (CH) and extended hepatectomy (EH) groups. BACKGROUND: Surgical choices for centrally located liver tumours are limited. The traditional EH harbours substantial risks, whereas CH i ...
Full textLink to itemCite
Journal ArticleAnal Chem · October 6, 2015
Experiments involving the high-throughput quantification of image data require algorithms for automation. A challenge in the development of such algorithms is to properly interpret signals over a broad range of image characteristics, without the need for m ...
Full textLink to itemCite
ConferenceHPB (Oxford) · October 2015
BACKGROUND: Biliary cystic tumours (BCT) [biliary cystadenoma (BCA) and cystadenocarcinoma (BCAC)] warrant complete resection. Simple liver cysts (SLC) require fenestration when symptomatic. Distinguishing between BCT and atypical SLC with pre-operative im ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · October 2015
BACKGROUND: Reports show that FOLFIRINOX therapy for pancreatic ductal adenocarcinoma (PDAC) results in objective response rates two to threefold higher than those of other regimens. This study aimed to assess response and resection rates for locally unres ...
Full textLink to itemCite
ConferenceAnn Surg · September 2015
OBJECTIVES: The impact of margin width on overall survival (OS) in the context of other prognostic factors after resection for colorectal liver metastases is unclear. We evaluated the relationship between resection margin and OS utilizing high-resolution h ...
Full textLink to itemCite
Journal ArticleAnn Oncol · September 2015
BACKGROUND: The objective of this study was to derive and validate a prognostic nomogram to predict disease-specific survival (DSS) after a curative intent resection of perihilar cholangiocarcinoma (PHC). PATIENTS AND METHODS: A nomogram was developed from ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · September 2015
BACKGROUND: The role of carcinoembryonic antigen (CEA) in surveillance and follow-up of patients with colorectal cancer continues to be debated. The objective of this study was to assess the utility of postoperative CEA as a predictor of recurrence for pat ...
Full textLink to itemCite
Journal ArticleLancet · August 22, 2015
BACKGROUND: Up-to-date evidence about levels and trends in disease and injury incidence, prevalence, and years lived with disability (YLDs) is an essential input into global, regional, and national health policies. In the Global Burden of Disease Study 201 ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · August 2015
PURPOSE: Patients with recurrence after complete resection of colorectal liver metastases (CLM) are considered for repeat resection as a potential salvage therapy (PST). However, outcomes for this approach are not well defined. We sought to analyze the nat ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · August 2015
BACKGROUND: Published prognostic models for overall survival after liver resection for intrahepatic cholangiocarcinoma require external validation before use in clinical practice. STUDY DESIGN: From January 1993 to May 2013, consecutive patients who underw ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · August 2015
BACKGROUND: The optimal perioperative fluid resuscitation strategy for liver resections remains undefined. Goal-directed therapy (GDT) embodies a number of physiologic strategies to achieve an ideal fluid balance and avoid the consequences of over- or unde ...
Full textLink to itemCite
Journal ArticleNat Commun · July 7, 2015
Pancreatic adenocarcinoma has the worst mortality of any solid cancer. In this study, to evaluate the clinical implications of genomic alterations in this tumour type, we perform whole-exome analyses of 24 tumours, targeted genomic analyses of 77 tumours, ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · July 2015
BACKGROUND: The prognostic and predictive abilities of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) coupled with conventional computed tomography (CT) have not been studied in patients with unresectable colorectal liver metastases (uCRLM ...
Full textLink to itemCite
Journal ArticleAm J Surg · June 2015
BACKGROUND: One quarter of colorectal cancer patients will present with liver metastasis at the time of diagnosis. Recent studies have shown that simultaneous resections are safe and feasible for stage IV colon cancer. Limited data are available for simult ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · May 2015
BACKGROUND: Intraductal papillary mucinous neoplasms (IPMN) are being increasingly recognized as important precursors to pancreatic adenocarcinoma. Elucidation of the genetic changes underlying IPMN carcinogenesis may improve the diagnosis and management o ...
Full textLink to itemCite
Chapter · April 7, 2015
Segmental anatomic pancreatectomy with lymph node dissection is currently the most commonly reported technique for the operative management of intraductal papillary mucinous neoplasm (IPMN). More limited resection (enucleation or central pancreatectomy) ma ...
Full textCite
ConferenceJ Am Coll Surg · April 2015
BACKGROUND: Liver resection is used to treat primary and secondary malignancies. Historically, these procedures were associated with significant complications, which may affect cancer-specific outcomes. This study analyzed the changes in morbidity and mort ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · April 2015
INTRODUCTION: Primary pancreatic lymphoma (PPL) is a rare tumor that is often misdiagnosed. Clinicopathologic features, optimal therapy, and outcomes are not well defined. We reviewed our institutional experience with PPL. METHODS: Search of our institutio ...
Full textLink to itemCite
ConferenceJ Am Coll Surg · March 2015
BACKGROUND: In patients with colorectal cancer liver metastases (CRCLM), chemotherapy-induced hepatic injury is associated with increased splenic volume, thrombocytopenia, and decreased long-term survival. The current study investigates the relationship be ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · March 2015
BACKGROUND: Texture analysis is a promising method of analyzing imaging data to potentially enhance diagnostic capability. This approach involves automated measurement of pixel intensity variation that may offer further insight into disease progression tha ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · March 2015
OBJECTIVES: Low central venous pressure (LCVP)-assisted hepatectomy is associated with decreased blood loss and lower transfusion rates. Concerns about its impact on renal function have prevented widespread application. This study was conducted to review t ...
Full textLink to itemCite
Journal ArticleSemin Oncol · February 2015
Due to increasing utilization of cross-sectional imaging, asymptomatic pancreatic cysts are frequently being diagnosed. Many of these cysts have premalignant potential and offer a unique opportunity for cancer prevention. Mucinous cystic neoplasm and intra ...
Full textLink to itemCite
Journal ArticleAnn Surg · February 2015
PURPOSE: Evaluate conversion rate of patients with unresectable colorectal-liver metastasis to complete resection with hepatic-arterial infusion plus systemic chemotherapy including bevacizumab (Bev). PATIENTS AND METHODS: Forty-nine patients with unresect ...
Full textLink to itemCite
Journal ArticleSurgery · February 2015
BACKGROUND: Hospital readmission rates after surgery are increasingly used as a measure of quality of care. Numerous efforts to decrease these rates have been established by care providers and insurance companies. There is sparse information available rega ...
Full textLink to itemCite
Journal ArticlePLoS One · 2015
The validation of candidate biomarkers often is hampered by the lack of a reliable means of assessing and comparing performance. We present here a reference set of serum and plasma samples to facilitate the validation of biomarkers for resectable pancreati ...
Full textLink to itemCite
Journal ArticlePLoS One · 2015
PURPOSE: To investigate associations between imaging features of cholangiocarcinoma by visual assessment and texture analysis, which quantifies heterogeneity in tumor enhancement patterns, with molecular profiles based on hypoxia markers. METHODS: The inst ...
Full textLink to itemCite
Journal ArticleBr J Surg · January 2015
BACKGROUND: Microwave ablation has emerged as a promising treatment for liver malignancies, but there are scant long-term follow-up data. This study evaluated long-term outcomes, with a comparison of 915-MHz and 2.4-GHz ablation systems. METHODS: This was ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · January 2015
BACKGROUND: The indications for minimally invasive (MIS) pancreatectomy have slowly increased as experience, techniques, and technology have improved and evolved to manage malignant lesions in selected patients without compromising safety and oncologic pri ...
Full textLink to itemCite
Journal ArticleCancer · December 15, 2014
BACKGROUND: The validity of the KRAS mutation as a predictor of recurrence-free survival (RFS) or overall survival (OS) is unclear. The current study investigated whether the presence of the KRAS mutation decreased RFS or OS in patients with colorectal can ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · December 2014
BACKGROUND: Microwave (MWA) and radiofrequency ablation (RFA) are the most commonly used techniques for ablating colorectal-liver metastases (CRLM). The technical and oncologic differences between these modalities are unclear. METHODS: We conducted a match ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · December 2014
BACKGROUND: Readmission rates have been targeted for cost/reimbursement control. Our goal was to identify causes for readmission and delineate the pattern of early and late readmission. METHODS: Between 2011 and 2012, a total of 490 patients underwent panc ...
Full textLink to itemCite
ConferenceHPB (Oxford) · December 2014
OBJECTIVES: This study was conducted to evaluate the prognostic value of, respectively, the 6th and 7th editions of the American Joint Committee on Cancer (AJCC) staging system for patients with resected perihilar cholangiocarcinoma (PHC). METHODS: Patient ...
Full textLink to itemCite
Journal ArticleAJR Am J Roentgenol · November 2014
OBJECTIVE: The purpose of this retrospective study was to measure interobserver agreement in the assessment of malignant imaging features of intraductal papillary mucinous neoplasms (IPMNs) on MDCT. MATERIALS AND METHODS: Pancreatic protocol CT studies wer ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · November 2014
BACKGROUND: Current pre-operative staging methods for gallbladder cancer (GBC) are suboptimal in detecting metastatic disease. Positron emission tomography (PET) may have a role but data are lacking. METHODS: Patients with GBC and PET assessed by a hepatob ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · October 2014
BACKGROUND: The reliable prediction of hepatocellular carcinoma (HCC) recurrence patterns potentially allows for the prioritization of patients for liver resection (LR) or transplantation. OBJECTIVES: The aim of this study was to analyse clinicopathologica ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · October 2014
BACKGROUND: After portal vein embolization (PVE), the future liver remnant (FLR) hypertrophies for several weeks. An early marker that predicts a low risk of post-hepatectomy liver failure can reduce the delay to surgery. STUDY DESIGN: Liver volumes of 153 ...
Full textLink to itemCite
Journal ArticleLancet · September 13, 2014
BACKGROUND: The fifth Millennium Development Goal (MDG 5) established the goal of a 75% reduction in the maternal mortality ratio (MMR; number of maternal deaths per 100,000 livebirths) between 1990 and 2015. We aimed to measure levels and track trends in ...
Full textLink to itemCite
Journal ArticleLancet · September 13, 2014
BACKGROUND: The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal (MDG) 6. The Global Burden of Disease 2013 study provides a consistent and comprehensiv ...
Full textLink to itemCite
Journal ArticleFam Cancer · September 2014
Cowden syndrome is an autosomal dominant condition caused by pathogenic mutations in the phosphatase and tensin homolog (PTEN) gene. Only a small proportion of identified pathogenic mutations have been reported to be large deletions and rearrangements. We ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · September 2014
BACKGROUND: Residual disease (RD) at definitive resection of incidental gallbladder cancer (IGBCA) influences outcome, but its clinical relevance with respect to anatomic site is incompletely characterized. STUDY DESIGN: Consecutive patients with IGBCA und ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · August 2014
BACKGROUND: For patients with unresectable intrahepatic cholangiocarcinoma (ICC), treatment options are limited and survival is poor. This study summarizes the long-term outcome of two previously reported clinical trials using hepatic arterial infusion (HA ...
Full textLink to itemCite
Journal ArticleAnn Surg · July 2014
BACKGROUND: The role for neoadjuvant systemic therapy in resectable pancreas adenocarcinoma remains undefined. OBJECTIVE: We evaluated the efficacy of gemcitabine and oxaliplatin administered as preoperative therapy in patients with resectable pancreas ade ...
Full textLink to itemCite
Journal ArticleCancer Immunol Res · June 2014
Tumor-infiltrating lymphocytes (TIL) in colorectal cancer liver metastases (CLM) have been associated with more favorable patient outcomes, but whether MHC class I (MHC-I) expression on cancer cells affects prognosis is uncertain. Immunohistochemistry was ...
Full textLink to itemCite
Journal ArticleN Engl J Med · May 22, 2014
BACKGROUND: Postoperative pancreatic fistula is a major contributor to complications and death associated with pancreatic resection. Pasireotide, a somatostatin analogue that has a longer half-life than octreotide and a broader binding profile, decreases p ...
Full textLink to itemCite
Journal ArticleProc Natl Acad Sci U S A · May 13, 2014
The ability of cancer cells to invade along nerves is associated with aggressive disease and diminished patient survival rates. Perineural invasion (PNI) may be mediated by nerve secretion of glial cell line-derived neurotrophic factor (GDNF) attracting ca ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · May 2014
BACKGROUND: Risk of high-grade dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms (IPMN) of the pancreas is increased in main duct compared to branch duct lesions. We hypothesized that isolated uncinate duct dilation may also be a ...
Full textLink to itemCite
ConferenceAm J Surg Pathol · April 2014
BACKGROUND: In the pancreas, poorly differentiated neuroendocrine carcinomas include small cell carcinoma and large cell neuroendocrine carcinoma and are rare; data regarding their pathologic and clinical features are very limited. DESIGN: A total of 107 p ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · March 2014
BACKGROUND: Patients with biliary tract adenocarcinoma with nodal involvement have a poor prognosis. There is currently no standardized method for intraoperative lymph node assessment. The current study aimed to determine the prognostic significance of the ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · March 2014
BACKGROUND: Two-stage hepatectomy (TSH) has been adopted as a treatment modality for resection of advanced colorectal liver metastases (CRLM). This study analyzed the recurrence pattern, salvage rate, and survival after TSH combined with systemic and regio ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · March 2014
BACKGROUND: Duodenal neuroendocrine tumors are rare and few studies exist to guide surgical management. This study identifies factors associated with recurrence after resection. METHODS: A retrospective, single institution review was performed between 1983 ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · March 2014
OBJECTIVES: The timing of major elective operations is a potentially important but rarely examined outcome variable. This study examined elective pancreaticoduodenectomy (PD) timing as a perioperative outcome variable. METHODS: Consecutive patients submitt ...
Full textLink to itemCite
Journal ArticleSci Transl Med · February 19, 2014
The development of noninvasive methods to detect and monitor tumors continues to be a major challenge in oncology. We used digital polymerase chain reaction-based technologies to evaluate the ability of circulating tumor DNA (ctDNA) to detect tumors in 640 ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · February 2014
PURPOSE: Systemic bevacizumab (Bev) was added to hepatic arterial infusion (HAI) floxuridine (FUDR)-based chemotherapy in three studies in an attempt to improve outcomes. A specific review of biliary toxicity was carried out. METHODS: This analysis include ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · February 2014
INTRODUCTION: Pharmacologic prophylaxis (PP) is recommended for patients undergoing general surgical procedures with at least moderate risk of venous thromboembolism (VTE). The role of PP in patients undergoing hepatectomy is controversial, however, due to ...
Full textLink to itemCite
Journal ArticlePLoS One · 2014
BACKGROUND: Combined intra-operative ablation and resection (CARe) is proposed to treat extensive colorectal liver metastases (CLM). This multicenter study was conducted to evaluate overall survival (OS), local recurrence-free survival (LRFS), hepatic recu ...
Full textLink to itemCite
Journal ArticlePLoS One · 2014
BACKGROUND: The clinical management of pancreatic cancer is severely hampered by the absence of effective screening tools. METHODS: Sixty-seven biomarkers were evaluated in prediagnostic sera obtained from cases of pancreatic cancer enrolled in the Prostat ...
Full textLink to itemCite
Journal ArticleJournal of the American College of Surgeons · January 1, 2014
Background Pancreatic leak is a major cause of morbidity after pancreatectomy. Traditionally, peripancreatic fluid collections have been managed by percutaneous or operative drainage. Data for endoscopic ultrasound (EUS)-guided drainage of postoperative fl ...
Full textCite
Journal ArticleJ Surg Oncol · January 2014
Isolated pancreatic metastases may occur in patients with many types of cancer. Several retrospective case series have been published demonstrating the feasibility of resection in selected patients. Here we report our experience with pancreatic metastasect ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · December 2013
BACKGROUND: Additional chemotherapy in patients with resectable colorectal liver metastases (CRLM) likely improves outcomes. Whether to administer chemotherapy as perioperative or adjuvant therapy remains controversial. We analyzed outcomes between these t ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · December 2013
BACKGROUND: Clinical decision making for patients with intraductal papillary mucinous neoplasms (IPMN) of the pancreas is challenging. Even with strict criteria for resection, most resected lesions lack high-grade dysplasia (HGD) or invasive carcinoma. MET ...
Full textLink to itemCite
Journal ArticleJAMA Surgery · December 1, 2013
IMPORTANCE Portal vein embolization improves the safety of liver resection by increasing the size of residual liver, but the embolization may increase tumor growth during the waiting period before definitive hepatectomy. OBJECTIVE To determine whether the ...
Full textCite
Journal ArticleAnn Surg · December 2013
BACKGROUND: The only prospective randomized trial evaluating the use of intraperitoneal drainage following pancreatic resection was published from our institution approximately 10 years ago. The current study sought to evaluate the evolution of practice ov ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · December 2013
BACKGROUND: Jehovah's Witness (JW) patients undergoing liver or pancreas surgery represent a challenging ethical and medical problem, with few reports about their optimal management. STUDY DESIGN: To analyze the perioperative outcomes of JW patients submit ...
Full textLink to itemCite
Journal ArticleMol Cell Proteomics · October 2013
Specific protein glycoforms may be uniquely informative about the pathological state of a cyst and may serve as accurate biomarkers. Here we tested that hypothesis using antibody-lectin sandwich arrays in broad screens of protein glycoforms and in targeted ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · October 2013
BACKGROUND: For patients undergoing liver resection for colorectal metastases, specific clinico-pathological variables have been shown to be prognostic at baseline. This study analyses how the prognostic capability of these variables changes in a condition ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · October 2013
BACKGROUND: The significance of a positive margin in resected non-invasive pancreatic intraductal papillary mucinous neoplasms (IPMN) remains controversial. The aim of this study was to determine recurrence rates when dysplasia was present at the final sur ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · October 2013
PURPOSE: Pancreatic intraepithelial neoplasia (PanIN) is a presumed precursor of pancreatic ductal adenocarcinoma (PDAC). We assessed the relationship between incidental PanIN after resection of non-adenocarcinoma lesions and the development of metachronou ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · September 2013
BACKGROUND: When feasible, surgical treatment of colorectal liver metastases (CRLM) is the treatment of choice. Regional hepatic artery infusional (HAI) chemotherapy effectively treats CRLM. The combination of HAI and systemic chemotherapy may downsize tum ...
Full textLink to itemCite
Journal ArticleAnticancer Res · August 2013
BACKGROUND/AIM: Data on the clinicopathological features and prognostic impact of c-N-Methyl-N'-nitro-N-nitroso-guanidine HOS Transforming gene (c-MET) and hepatocyte growth factor (HGF) in hepatocellular carcinoma (HCC) are inconsistent. We assessed c-MET ...
Link to itemCite
Journal ArticleSurgery · August 2013
BACKGROUND: The incidence of internal hernia (IH) after gastrectomy for cancer with Roux-Y reconstruction has not been well-defined. This study aimed to define the true incidence of IH after gastrectomy for cancer with Roux-Y reconstruction; to describe th ...
Full textLink to itemCite
Journal ArticleAnn Surg · August 2013
OBJECTIVE: To determine whether SMAD4 expression is associated with recurrence pattern after resection for pancreatic ductal adenocarcinoma (PDA). BACKGROUND: SMAD4 expression status has been reported to be associated with patterns of failure in PDA, but s ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · August 2013
BACKGROUND: Perioperative outcomes, such as blood loss, transfusions, and morbidity, have been linked to cancer-specific survival, but this is largely unsupported by prospective data. METHODS: Patients from a previous, randomized trial that evaluated acute ...
Full textLink to itemCite
Journal ArticleJAMA Surg · July 2013
IMPORTANCE: Ablative therapies extend the capability of delivering potentially curative treatment for bilateral hepatic colorectal metastases. OBJECTIVE: To compare the long-term effectiveness of ablation with that of resection in patients with bilateral h ...
Full textLink to itemCite
Journal ArticleAm J Gastroenterol · July 2013
OBJECTIVES: Controversy exists regarding whether to place a plastic or a metal endobiliary stent in patients with resectable pancreatic cancer who require biliary drainage. Although self-expandable metal stents (SEMS) provide better drainage compared with ...
Full textLink to itemCite
Journal ArticleAJR Am J Roentgenol · June 2013
OBJECTIVE: Iodinated contrast agent for CT has a short half-life in the vasculature. As the field of interventional procedures expands, a more durable contrast agent would be highly useful. Our study investigated whether gold nanoparticles are feasible as ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · June 2013
INTRODUCTION: Traditionally, rates of irresectable disease at laparotomy for colorectal liver metastases (CRLM) have ranged from 15 to 70%. Diagnostic laparoscopy has been shown to be effective at preventing nontherapeutic laparotomy in selected patients. ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · June 2013
BACKGROUND: The hepatic artery lymph node (HALN) is frequently sampled during pancreaticoduodenectomy (PD). Data suggest that survival in the setting of HALN metastases is similar to that of stage IV pancreatic ductal adenocarcinoma (PDAC). The objectives ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · June 2013
BACKGROUND: Intrahepatic pedicle ligation (IPL) is an alternative to extrahepatic portal dissection (EPD). Although IPL has been well described, concern has arisen over a possible association with increased complication rates. METHODS: Patients who underwe ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · April 2013
BACKGROUND: Considerable debate exists as to appropriate perioperative fluid management. Data from several studies suggest that the amount of fluid administered perioperatively influences surgical outcome. Pancreatic resection is a major procedure in which ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · March 2013
INTRODUCTION: Hepatocellular adenoma (HA) is an uncommon benign hepatic tumour with the potential for malignant change or spontaneous haemorrhage. Resection has been the recommended treatment, but outcomes with other approaches are ill defined. METHODS: De ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · February 2013
BACKGROUND: Intraductal papillary mucinous neoplasms (IPMN) may represent a field defect of pancreatic ductal instability. The relative risk of carcinoma in regions remote from the radiographically identified cyst remains poorly defined. This study describ ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · February 2013
OBJECTIVES: Benign liver tumours (BLTs) are common and their management remains controversial. This study assesses the safety of a selective management approach. METHODS: Patients with BLT were identified from an institutional database. Patients with simpl ...
Full textLink to itemCite
Journal ArticlePLoS One · 2013
PURPOSE: The aim of this study was to build a molecular prognostic model based on gene signatures for patients with completely resected hepatic metastases from colorectal cancer (MCRC). METHODS: Using the Illumina HumanHT-12 gene chip, RNA samples from the ...
Full textLink to itemCite
Journal ArticleSurgical Endoscopy · January 1, 2013
Background: Peripancreatic fluid collections (PFCs) occur in up to 30 % of patients following partial pancreatic resections. Traditionally, postoperative PFCs are managed via percutaneous drainage (PD). EUS-guided transgastric drainage has been shown to be ...
Full textCite
ConferenceHPB · January 1, 2013
Background Neoadjuvant chemoradiation therapy for locally unresectable and borderline resectable pancreatic cancer may allow some patients to a undergo a resection, but whether or not this increases post-operative morbidity remains unclear. Methods The pos ...
Full textCite
Journal ArticleAnn Surg Oncol · January 2013
INTRODUCTION: Outcome after hepatic resection for colorectal cancer liver metastases (CRLM) is heterogeneous and accurate predictors of survival are lacking. This study analyzes the prognostic relevance of pathologic details of the primary colorectal tumor ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · January 2013
BACKGROUND: Hepatic pedicle clamping is often used during liver resection. While its use reduces blood loss and transfusion requirements, the long-term effect on survival and recurrence has been debated. This study evaluates the effect of hepatic pedicle c ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · January 2013
BACKGROUND: Patients undergoing liver resection for colorectal cancer liver metastasis (CRCLM) are often treated with chemotherapy before surgery. However, the associations between chemotherapy, liver injury, perioperative outcomes, and other confounding f ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · December 2012
BACKGROUND: Surgical approach is an accepted approach for metastatic neuroendocrine tumors (NET), but the safety and effectiveness of synchronous liver metastases resection with primary and/or locally recurrent NET is unclear. METHODS: From 1992 to 2009, a ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · December 2012
BACKGROUND AND OBJECTIVES: Hepatic arterial infusional (HAI) chemotherapy combined with systemic chemotherapy is effective palliative therapy for unresectable colorectal cancer liver metastases (CRLM). Some patients considered for HAI have evidence of mini ...
Full textLink to itemCite
Journal ArticleCancer · November 1, 2012
BACKGROUND: The optimal combination of available therapies for patients with resectable synchronous liver metastases from rectal cancer (SLMRC) is unknown, and the pattern of recurrence after resection has been poorly investigated. In this study, the autho ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · November 2012
BACKGROUND: Postpancreatectomy hemorrhage (PPH) is a life-threatening complication of pancreatic resection. Most published series span decades and do not reflect contemporary practice. This study analyzes the rate, management, and outcomes of PPH during a ...
Full textLink to itemCite
Journal ArticleHepatology · October 2012
UNLABELLED: Intraductal papillary neoplasm of the bile duct (IPNB) is a variant of bile duct carcinoma characterized by intraductal growth and better outcome compared with the more common nodular-sclerosing type. IPNB is a recognized precursor of invasive ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · September 2012
BACKGROUND: Epidemiologic studies have reported a positive correlation between body mass index (BMI) and pancreatic cancer risk, but clinical relevance of obesity and/or body fat distribution on tumor characteristics and cancer-related outcome remain contr ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · September 2012
BACKGROUND: Pathologic response to preoperative chemotherapy for colorectal liver metastases (CLM) is associated with survival after hepatectomy. Histologically, dominant response patterns include fibrosis, necrosis and/or acellular mucin, but some of thes ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · September 1, 2012
PURPOSE: In mice, genetic changes that inactivate the retinoblastoma tumor suppressor pathway often result in pancreatic neuroendocrine tumors (Pan-NETs). Conversely, in humans with this disease, mutations in genes of the retinoblastoma pathway have rarely ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · September 2012
BACKGROUND: Ablation is increasingly used to treat primary and secondary liver cancer. Ablation near portal pedicles and hepatic veins is challenging. Irreversible electroporation (IRE) is a new ablation technique that does not rely on heat and, in animals ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · September 2012
BACKGROUND: Complete resection of hilar cholangiocarcinoma (HCCA) is a critical determinant of long-term survival. This study validates a previously reported preoperative clinical T staging system for determining resectability of HCCA. STUDY DESIGN: Consec ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · August 2012
BACKGROUND: Adrenocortical carcinoma (ACC) liver metastases (LM) represent a therapeutic challenge, and it is unclear whether resection is justified. This study assesses long-term outcome and prognostic factors after liver resection for metastatic ACC. MET ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · July 2012
BACKGROUND: The purpose of this study was to determine if the expression of the chemokine receptors, CXCR4 and CCR7, and the chemokine ligand, CXCL12, in completely resected colorectal cancer hepatic metastases are predictive of disease-specific survival, ...
Full textLink to itemCite
Journal ArticleCancer · July 1, 2012
BACKGROUND: Merkel cell carcinoma (MCC) is a rare cutaneous neuroendocrine neoplasm whose natural history is poorly understood. Here, the authors describe their experience with a large cohort of patients who were treated at a single institution to describe ...
Full textLink to itemCite
Journal ArticleJ Proteome Res · May 4, 2012
Significant efforts are underway to develop new biomarkers from pancreatic cyst fluid. Previous research has made use of cyst fluid collected from surgically removed cysts, but the clinical implementation of biomarkers would use cyst fluid collected by end ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · May 2012
BACKGROUND: Positive peritoneal cytology confers the same prognosis as clinical stage IV disease in gastric cancer. Conventional cytology examination, however, has low sensitivity. We hypothesize that real-time polymerase chain reaction (RT-PCR) may have i ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · May 2012
BACKGROUND: Patients with locally unresectable pancreatic cancer (AJCC stage III) have a median survival of 10-14 months. The objective of this study was to evaluate outcome of initially unresectable patients who respond to multimodality therapy and underg ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · May 2012
BACKGROUND: Hepatic arterial infusion pump chemotherapy (HAIPC) contributes to the prolonged survival of selected patients with colorectal cancer liver metastases (CRCLM). The most clinically important adverse event after HAIPC with floxuridine (FUDR) is b ...
Full textLink to itemCite
Journal ArticleSurgery · April 2012
INTRODUCTION: Cystic pancreatic endocrine neoplasms (CPENs) are uncommon tumors with uncertain disease biology and ill-defined diagnostic features. METHODS: A prospectively maintained pancreatic cyst registry was queried, and 31 cases of CPEN that were res ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · March 2012
PURPOSE: To determine the local recurrence rate and factors associated with recurrence after intraoperative ablation of colorectal cancer liver metastases. METHODS: A retrospective analysis of a prospectively maintained database was performed for patients ...
Full textLink to itemCite
Journal ArticleSurgery · February 2012
BACKGROUND: The prognostic relevance of variations in expression of specific tumor genes in colorectal cancer liver metastases (CRCLMs) in patients treated with resection and modern chemotherapy is not known. METHODS: Patients submitted to liver resection ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · February 2012
BACKGROUND: In selected patients with incidental gallbladder carcinoma (GBCA) diagnosed after laparoscopic cholecystectomy (LC), definitive resection is warranted. Port site excision has been advocated but remains controversial. METHODS: Patients with GBCA ...
Full textLink to itemCite
Journal ArticlePLoS One · 2012
BACKGROUND: One-fifth of patients with seemingly 'curable' pancreatic ductal adenocarcinoma (PDA) experience an early recurrence and death, receiving no definable benefit from a major operation. Some patients with advanced stage tumors are deemed 'unresect ...
Full textLink to itemCite
Journal ArticleHPB · January 1, 2012
Background: The optimal surgical management of patients found to have unresectable pancreatic cancer at open exploration remains unknown. Methods: Records of patients who underwent non-therapeutic laparotomy for pancreatic cancer during 2000-2009 and were ...
Full textCite
Journal ArticleAnn Surg Oncol · January 2012
BACKGROUND: Randomized trials have demonstrated a benefit associated with adjuvant therapy for pancreatic cancer, and retrospective studies have demonstrated improvements in postoperative mortality. The purpose of this study was to evaluate whether these i ...
Full textLink to itemCite
Journal ArticleProc Natl Acad Sci U S A · December 27, 2011
More than 2% of adults harbor a pancreatic cyst, a subset of which progresses to invasive lesions with lethal consequences. To assess the genomic landscapes of neoplastic cysts of the pancreas, we determined the exomic sequences of DNA from the neoplastic ...
Full textLink to itemCite
Journal ArticleAnn Surg · December 2011
BACKGROUND: The potential benefit of adjuvant hepatic arterial infusional floxuridine (HAI-FUDR) in addition to modern systemic chemotherapy using oxaliplatin or irinotecan remains unknown for patients with resected liver-confined colorectal metastases (CR ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · December 2011
BACKGROUND: A total of 750,000 cholecystectomies are performed annually in the USA. No data exist on patients with microscopic high-grade dysplasia at the cystic duct margin and the associated incidence of cholangiocarcinoma. METHODS: Pathology reports for ...
Full textLink to itemCite
Journal ArticleSurg Oncol · December 2011
INTRODUCTION: Schwannomas are usually benign nerve sheath tumors, which typically arise in the head, neck, spinal cord and extremities. Schwannoma of the biliary tract is an extremely rare finding. Patients generally lack symptoms and seek medical attentio ...
Full textLink to itemCite
Journal ArticleSurgery · November 2011
BACKGROUND: Despite improved clinical characterization, autoimmune pancreatitis is often still diagnosed only after a major operative procedure. This study seeks to elucidate the circumstances that contribute to an inaccurate preoperative diagnosis. METHOD ...
Full textLink to itemCite
Journal ArticleMod Pathol · September 2011
Folate receptor alpha (FRα), encoded by folate receptor 1 (adult) gene, has emerged as a cancer biomarker and potential therapeutic target. In addition, its expression in tumors may offer prognostic information. The aim of this study was to assess the prog ...
Full textLink to itemCite
Journal ArticleSurgery · September 2011
BACKGROUND: Liver angiomyolipomas (AML) are mesenchymal neoplasms with an uncertain clinical behavior. The spectrum of presentation, imaging and histologic features, and outcomes were analyzed in all patients treated at Memorial Sloan-Kettering Cancer Cent ...
Full textLink to itemCite
ConferenceAnn Surg · September 2011
OBJECTIVE: To identify factors associated with survival in Merkel cell carcinoma (MCC). BACKGROUND: Merkel cell carcinoma is a rare cutaneous neoplasm. Staging and treatment are based on studies, which incompletely characterize the disease. METHODS: Review ...
Full textLink to itemCite
Journal ArticleAnn Surg · August 2011
BACKGROUND: This study evaluates the significance of tumor involvement of the liver in early T-stage tumors and lymph node (LN) metastases on outcome after R0 resection of gallbladder cancer (GBCA). METHODS: A prospectively maintained database, supplemente ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · August 2011
BACKGROUND: This study utilized the imaging data of primary liver cancer (PLC) treated with floxuridine (FUDR) and bevacizumab to test the hypothesis that dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters correlate with tissue hypox ...
Full textLink to itemCite
Journal ArticleSci Transl Med · July 20, 2011
More than 2% of the adult U.S. population harbors a pancreatic cyst. These often pose a difficult management problem because conventional criteria cannot always distinguish cysts with malignant potential from those that are innocuous. One of the most commo ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · July 2011
OBJECTIVE: To evaluate the role of intraoperative ablation as an adjunct to resection in patients with recurrent colorectal liver metastases (rCLM). METHODS: All patients undergoing curative-intent reoperative surgery for rCLM from 1992 to 2009 at a tertia ...
Full textLink to itemCite
Journal ArticleCancer · June 15, 2011
BACKGROUND: Inclusion of minorities is an important but challenging aspect of epidemiologic studies in the United States. One aspect of this challenge that has received little attention is the actual number of minorities with specific cancers. The authors ...
Full textLink to itemCite
Journal ArticleSurg Endosc · May 2011
BACKGROUND: Laparoscopic liver surgery has become a safe and effective approach to the surgical management of liver disease. Recently developed, single-port-access surgery is of growing interest in an attempt to minimize abdominal wall trauma. Various abdo ...
Full textLink to itemCite
Journal ArticleAnn Surg · May 2011
OBJECTIVE: The purpose of this study was to characterize the clinicopathological features of invasive carcinomas arising in intraductal papillary mucinous neoplasms of the pancreas (IPMN) by histological subtype of the invasive component and to compare the ...
Full textLink to itemCite
Journal ArticleAm J Gastroenterol · May 2011
OBJECTIVES: Pancreatic adenocarcinoma is a lethal disease. Over 80% of patients are found to have metastatic disease at the time of diagnosis. Strategies to improve disease-specific outcome include identification and early detection of precursor lesions or ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · April 2011
BACKGROUND: Cystic lesions of the pancreas are being identified more frequently, and a selective approach to resection is now recommended. The aim of this study was to assess the change in presentation and management of pancreatic cystic lesions evaluated ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · March 15, 2011
PURPOSE: Biomarkers for high-grade dysplasia in patients with radiographically identified intraductal papillary mucinous neoplasms (IPMN) have not been described. We hypothesized that dysplasia in IPMN invokes an immunogenic/proinflammatory microenvironmen ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · March 2011
INTRODUCTION: The efficacy of laparoscopic celiac plexus block (CPB) in patients with unresectable pancreatic cancer has not been reported. METHODS: Patients with elevated pain scores scheduled for laparoscopy for diagnosis/staging of unresectable pancreat ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · February 15, 2011
PURPOSE: Serum-biomarker based screening for pancreatic cancer could greatly improve survival in appropriately targeted high-risk populations. EXPERIMENTAL DESIGN: Eighty-three circulating proteins were analyzed in sera of patients diagnosed with pancreati ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · February 2011
BACKGROUND: Solid pseudopapillary tumors of the pancreas (SPT) are rare neoplasms, and the natural history is poorly defined. The aim of this study was to define the natural history and compare patient and tumor factors between patients with malignant and ...
Full textLink to itemCite
Journal ArticleOncologist · 2011
BACKGROUND: Acinar cell carcinoma (ACC) of the pancreas is a rare neoplasm, accounting for 1% of all pancreatic neoplasms. There remains a lack of data regarding the use of systemic therapy in this disease. We present a series of 40 consecutive cases of AC ...
Full textLink to itemCite
Journal ArticleOncologist · 2011
BACKGROUND: BRCA1 and BRCA2 germline mutations are associated with an elevated risk for pancreas adenocarcinoma (PAC). Other BRCA-associated cancers have been shown to have greater sensitivity to platinum and poly(ADP-ribose) polymerase (PARP) inhibitors w ...
Full textLink to itemCite
Journal ArticleOncology · 2011
OBJECTIVES: This study investigated the efficacy and safety of adding systemic (IV) bevacizumab (Bev) to hepatic arterial infusion (HAI) with floxuridine (FUDR)/dexamethasone (Dex) in unresectable primary liver cancer. METHODS: Patients with unresectable i ...
Full textLink to itemCite
Journal ArticleClinical Colorectal Cancer · January 1, 2011
The presence of neuroendocrine cells in adenocarcinomas is not an unusual finding and is well described in gastrointestinal tract cancers, eg, colorectal cancer and gastric cancer. Genetic analysis of such tumors has suggested a common multipotent progenit ...
Full textCite
Journal ArticleAnn Surg Oncol · January 2011
INTRODUCTION: There are no reliable markers of dysplasia in patients with incidentally discovered intraductal papillary mucinous neoplasms of the pancreas (IPMN). IPMN dysplasia may be associated with mucin protein (MUC) expression and histopathologic subt ...
Full textLink to itemCite
Journal ArticleHPB · January 1, 2011
Background: The role of staging laparoscopy (SL) in patients with incidental gallbladder cancer (IGBC) is ill defined. This study evaluates the utility of SL with the aim of identifying variables associated with disseminated disease (DD). Methods: Consecut ...
Full textCite
Journal ArticleJ Am Coll Surg · January 2011
BACKGROUND: Gallbladder cancer (GBCA) is a rare malignancy with a variable incidence worldwide. This study analyzed GBCA patients treated at centers in 3 countries. The aim was to assess for location-specific differences in presentation and outcomes, which ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · December 2010
BACKGROUND: Although cyst fluid carcinoembryonic antigen (CEA; > 192 ng/ml) is the preferred test for identifying mucinous pancreatic cysts, the data are more robust for mucinous cystic neoplasms (MCN) than for intraductal papillary mucinous neoplasms (IPM ...
Full textLink to itemCite
Journal ArticleGenes and Cancer · December 1, 2010
Neuroendocrine tumors (NETs) comprise a group of rare tumors derived from the diffuse neuroendocrine system or islet endocrine cells of the pancreas. The molecular mechanisms underlying NETs are largely unknown. The tumor suppressor p53 plays a critical ro ...
Full textCite
Journal ArticleAnn Surg · December 2010
BACKGROUND: Pancreaticoduodenectomy (PD) can be associated with significant blood loss and transfusion requirements, with potential adverse short- and long-term consequences. The aim of this study was to determine whether acute normovolemic hemodilution (A ...
Full textLink to itemCite
Journal ArticleInt J Cancer · November 15, 2010
Survival from pancreatic adenocarcinoma remains extremely poor, approximately 5% at 5 years. Risk factors include smoking, high body mass index (BMI), family history of pancreatic cancer, and long-standing diabetes; in contrast, allergies are associated wi ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · October 2010
BACKGROUND: The pancreas remains an organ for which routine laparoscopic resection is uncommon. STUDY DESIGN: This is a review of all distal pancreatectomies performed between January 2003 and December 2009 at Memorial Sloan-Kettering Cancer Center. Variab ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · September 2010
BACKGROUND: Electronic synoptic operative reports (E-SORs) have replaced dictated reports at many institutions, but whether E-SORs adequately document the components and findings of an operation has received limited study. This study assessed the reliabili ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · August 2010
BACKGROUND: Tissue banking has become a major initiative at many oncology centers. The influence of warm ex-vivo ischemia times, storage times, and biobanking protocols on RNA integrity and subsequent microarray data is not well documented. METHODS: A pros ...
Full textLink to itemCite
Journal ArticleCardiovasc Intervent Radiol · June 2010
Hepatic encephalopathy is considered a contraindication to hepatic artery embolization. We describe a patient with a well-differentiated neuroendocrine tumor metastatic to the liver with refractory hepatic encephalopathy and normal liver function tests. Th ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · May 2010
BACKGROUND: This study analyzes factors associated with differences in long-term outcomes after hepatic resection for metastatic colorectal cancer over time. STUDY DESIGN: Sixteen-hundred consecutive patients undergoing hepatic resection for metastatic col ...
Full textLink to itemCite
Journal ArticleAnn Surg · April 2010
OBJECTIVE: To examine the importance of adequate lymph node sampling in staging of extrahepatic bile duct cancer (EHBDCA). SUMMARY OF BACKGROUND DATA: The American Joint Committee on Cancer staging manual (sixth edition) states that histologic examination ...
Full textLink to itemCite
Journal ArticleSurg Oncol Clin N Am · April 2010
Intraductal papillary mucinous neoplasms (IPMN) are mucinous cystic tumors of the pancreas, which were first classified into a unified diagnosis by the World Health Organization in 1996. These lesions originate from the cells of the pancreatic ductal syste ...
Full textLink to itemCite
Journal ArticleArch Surg · April 2010
OBJECTIVE: To determine the time course of liver hypertrophy after portal vein embolization (PVE). DESIGN: In a cohort study, computed tomography volumetrics were calculated for livers during a 1-year period after PVE. SETTING: Tertiary liver cancer treatm ...
Full textLink to itemCite
Journal ArticleMethods Mol Biol · 2010
This chapter describes the methodology by which mAb-F19-conjugated gold nanoparticles were prepared and used to label human pancreatic adenocarcinoma. Specifically, gold nanoparticles were coated with dithiol bearing hetero-bifunctional PEG (polyethylene g ...
Full textLink to itemCite
Journal ArticleHPB · January 1, 2010
Background: Tumour-infiltrating lymphocytes (TILs) have been shown to predict survival in numerous malignancies. The importance of TILs in primary pancreatic neuroendocrine tumours (NETs) and NET liver metastases (NETLMs) has not been defined. Methods: We ...
Full textCite
Journal ArticleJ Am Coll Surg · January 2010
BACKGROUND: CT imaging frequently detects subcentimeter pulmonary nodules (SPN) in patients undergoing resection of colorectal cancer liver metastases. Their clinical significance is unknown. STUDY DESIGN: Patients were identified who underwent hepatic res ...
Full textLink to itemCite
Journal ArticleSurg Oncol Clin N Am · January 2010
This article critically reviews and ranks 107 prospective, randomized controlled trials (RCT) for pancreatic adenocarcinoma published between 2000 and 2008 identified through a standard MEDLINE literature search strategy, according to a standardized, previ ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · December 2009
BACKGROUND: Positive peritoneal fluid cytology predicts poor outcome in patients with resected pancreatic cancer. Reverse transcription-polymerase chain reaction (RT-PCR) has been proposed as a more sensitive means of detection of peritoneal micrometastase ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · December 2009
BACKGROUND: Preoperative biliary drainage (PBD) prior to pancreaticoduodenectomy (PD) continues to be routine in many centers despite retrospective and randomized data showing that PBD increases perioperative infectious complications. METHODS: Review of a ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · December 2009
BACKGROUND: Laparoscopic liver resection (LLR) has become an increasingly popular operation; however, its theoretical benefits remain unproven. The aim of this study was to conduct a comparative outcome study between LLR and matched-pair open liver resecti ...
Full textLink to itemCite
Journal ArticleAnn Surg · November 2009
BACKGROUND: Many patients with benign serous cystadenoma (SCA) of the pancreas will undergo resection because of the inability to reliably discriminate between SCA and premalignant mucinous cysts (intraductal papillary mucinous neoplasm [IPMN], mucinous cy ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · November 2009
BACKGROUND: Most gastric carcinoid tumors (GC) (type I) occur in association with achlorhydria, hypergastrinemia, atrophic gastritis and exhibit low-grade histopathology. The management of this indolent disease is controversial. The aim of this study was t ...
Full textLink to itemCite
Journal ArticleHPB · August 1, 2009
Background: In patients with hilar cholangiocarcinoma, ipsilateral en bloc hepatic resection improves survival but is associated with increased morbidity. Preoperative biliary drainage of the future liver remnant (FLR) and contralateral portal vein emboliz ...
Full textCite
Journal ArticleAnn Surg Oncol · July 2009
OBJECTIVE: We investigated the relation between response to neoadjuvant chemotherapy and overall survival (OS) in patients with colorectal liver metastases (CLM). BACKGROUND: It has previously been reported that patients with synchronous CLM whose disease ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · July 1, 2009
BACKGROUND: There is a dearth of data in a younger population of patients with pancreatic ductal adenocarcinoma (PAC) regarding epidemiology, genetics, prognosis, and outcome. This report examines a large cohort of patients with PAC
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · June 2009
OBJECTIVE: The aim of this study is to compare technical feasibility and oncologic efficacy of totally laparoscopic versus open subtotal gastrectomy for gastric adenocarcinoma. BACKGROUND: Laparoscopic gastrectomy for adenocarcinoma is emerging in the West ...
Full textLink to itemCite
Journal ArticleJ Exp Clin Cancer Res · May 12, 2009
BACKGROUND: The pathogenesis of biliary cancers is ill-defined. This study investigates changes in gene expression and copy number in biliary cancers and correlates these changes with anatomical site of origin, histopathology and outcome. METHODS: We perfo ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · April 2009
BACKGROUND: Polypoid lesions of the gallbladder (PLG) are commonly seen on ultrasonography (US), but optimal management of this problem is ill-defined. The aims of this study were to assess the natural history and the histologic characteristics of US-detec ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · January 20, 2009
PURPOSE: The prognostic significance of germline BRCA1 and BRCA2 mutations in Jewish patients with pancreatic adenocarcinoma (PAC) is unknown. Our objective was to define the prevalence of BRCA1 and BRCA2 in an unselected group of Jewish patients and to co ...
Full textLink to itemCite
Journal ArticleJ Comput Assist Tomogr · 2009
OBJECTIVE: To characterize imaging features and findings in recurrent intraductal papillary mucinous neoplasms (IPMN); thereby reconciling the "field defect" theory with the appearance of recurrences distant from the resection margin. METHODS: Computed tom ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · December 2008
BACKGROUND: Staging laparoscopy for patients with radiographically resectable pancreatic adenocarcinoma has been reported to yield an 8-15% finding of unresectable disease. Factors associated with the likelihood of subradiographic unresectable disease have ...
Full textLink to itemCite
Journal ArticleACS Nano · November 25, 2008
In this study, we describe optical detection of antibody-conjugated nanoparticles bound to surgically resected human pancreatic cancer tissue. Gold nanoparticles stabilized by heterobifunctional polyethylene glycol (PEG) were prepared using approximately 1 ...
Full textLink to itemCite
ConferenceHPB · October 1, 2008
Purpose. Disease-specific survival (DSS) for proximal bile duct cancer has been reported to be worse than for carcinoma of the distal duct. Methods. Review of two prospectively maintained databases identified 204 patients who underwent resection for extrah ...
Full textCite
Journal ArticleSurgeon · October 2008
Over the last decade there has been a dramatic increase in the number of patients identified with pancreatic cysts. This increase has been largely attributed to advances in imaging. The majority of these cysts represent benign neoplasms; however, a signifi ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · October 2008
BACKGROUND: Anastomotic fistula, leak, and abscess are common complications of pancreatectomy. The goal of this study was to describe our current management and outcomes of clinically significant postpancreatectomy fistula, leak, and abscess. STUDY DESIGN: ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · April 2008
BACKGROUND: Most reports of patients undergoing resection for pancreatic adenocarcinoma report estimated (actuarial) 5-year survival rates. Actual 5-year survival is rarely described, and factors associated with long-term survival are not well described. M ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · March 2008
BACKGROUND: The routine use of staging laparoscopy in patients with radiographically resectable pancreatic and peripancreatic neoplasms remains controversial. STUDY DESIGN: We reviewed a prospective database that identified 1,045 patients who underwent sta ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · February 2008
BACKGROUND: The purpose of this study was to examine the preoperative patient and radiographic factors that are associated with operative morbidity after pancreaticoduodenectomy. MATERIAL AND METHODS: Patient characteristics and preoperative radiographic f ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · December 10, 2007
PURPOSE: The WHO classification for well-differentiated pancreatic endocrine neoplasms (PENs) incorporates both stage and grade. This study compares the prognostic value of a simplified staging and grading system with the WHO system in a large single-insti ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · December 2007
OBJECTIVE: Pancreatic cancer patients with positive (+) peritoneal cytology have a prognosis similar to stage IV patients. We studied the ability of quantitative real time-polymerase chain reaction (RT-PCR) to detect micrometastases in patients undergoing ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · November 2007
BACKGROUND: There is little information to determine prognosis or to guide clinical care for patients with duodenal adenocarcinoma. We have hypothesized that survival following resection of duodenal cancer is similar to survival following resection of dist ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · November 2007
BACKGROUND: The purpose of this study was to evaluate the significance of pathologic nodal assessment and extent of nodal metastases on patient outcome in patients with pancreatic adenocarcinoma. MATERIALS AND METHODS: A prospectively maintained pancreatic ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · May 2007
BACKGROUND: The risk of local recurrence in the pancreatic remnant after resection of noninvasive intraductal papillary mucinous neoplasm (IPMN) is not well defined. STUDY DESIGN: We performed a retrospective review of a prospectively maintained pancreatic ...
Full textLink to itemCite
Journal ArticleJ Clin Neurosci · April 2007
A soft tissue mass with an associated neuropathy suggests a malignancy with nerve compression or infiltration. However, there are benign diagnoses to consider. We report a case of an axillary mass with a radial nerve neuropathy, initially suspected to be a ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · March 2007
BACKGROUND: Improving surgical quality of care requires accurate reporting of postoperative complications. STUDY DESIGN: Accuracy of a prospective surgical complication grading database was assessed by performing a retrospective review of 204 pancreaticodu ...
Full textLink to itemCite
Book · 2007
The number of patients being identified as having asymptomatic small cysts of the pancreas is increasing. Most cystic neoplasms are SCAs, IPMNs, or MCNs. SCAs should be considered benign and in the absence of symptoms can be safely followed radiographicall ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · December 2006
The American Joint Committee on Cancer (AJCC) staging system for pancreatic adenocarcinoma classifies positive peritoneal cytology as stage IV disease. Data are limited with respect to the prevalence of positive peritoneal cytology and its influence on sur ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · December 2006
Previous studies have suggested that whole body positron-emission tomography (PET) can distinguish between benign and malignant cysts of the pancreas. Patients were identified (n = 68) who had undergone whole body PET imaging for a cystic lesion of the pan ...
Full textLink to itemCite
Journal ArticleAnn Surg · October 2006
OBJECTIVE: To define a group of patients with pancreatic cysts who do not require resection. SUMMARY BACKGROUND DATA: The increased use of cross-sectional imaging has resulted in an increased identification of small, asymptomatic pancreatic cysts. Data hav ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · July 2005
BACKGROUND: Hepatic arterial infusion pump chemotherapy is an important component in the treatment of patients with hepatic metastases. Successful use of a hepatic arterial infusion pump requires a low technical complication rate. We evaluated the complica ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · April 1, 2005
PURPOSE: Merkel cell carcinoma (MCC) is an uncommon cutaneous malignancy. Most reports consist of single-institution experiences of fewer than 30 patients. The natural history of MCC is poorly defined. PATIENTS AND METHODS: A review was performed of Memori ...
Full textLink to itemCite
Journal ArticleOphthalmic Surg Lasers Imaging · 2004
BACKGROUND AND OBJECTIVE: To report a modified erbium:YAG laser scalpel designed to incise tissue more efficiently and safely than other systems reported to date. MATERIALS AND METHODS: An erbium:YAG laser delivery system was built to deliver laser energy ...
Link to itemCite
ConferenceJ Gastrointest Surg · December 2003
Because of the inability to determine benign from malignant, many have recommended that all cystic lesions of the pancreas be resected. Patients evaluated between January 1995 and December 2000 for the ICD-9 diagnosis of pancreatic cyst (577.2) or benign n ...
Full textLink to itemCite
ConferenceJ Gastrointest Surg · December 2003
Fatty liver disease may interfere with liver regeneration and is postulated to result in an adverse outcome for patients subjected to partial hepatectomy. This study examines the impact of steatosis on outcome following hepatic resection for neoplasms. All ...
Full textLink to itemCite
Book · 2003
During the past 2 decades, an improved understanding of hepatic anatomy and advances in surgical technique have allowed for hepatic resection to be performed with operative mortality rates between 1% and 5%. With this low mortality, hepatic resection is no ...
Link to itemCite
Journal ArticleJ Gastrointest Surg · January 2003
The purpose of this study was to compare the treatment and outcome in patients referred for staged resection of synchronous colorectal liver metastases. The records of patients who had undergone colon or rectal resection and were then referred for evaluati ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · November 1, 2002
PURPOSE: To define prognostic factors for postrelapse survival and their time-dependent influence for adult soft tissue sarcoma (STS). PATIENTS AND METHODS: We analyzed 2,123 patients with completely resected localized primary STS treated from 1982 to 1999 ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · November 2002
BACKGROUND: The success of hepatic arterial infusion pump (HAIP) placement in patients with variant arterial anatomy has not been well described. METHODS: Patients who underwent HAIP placement over a 5-year time period were evaluated. Arterial- and cathete ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · October 2002
When deciding whether or not to perform a resection for metastatic melanoma, one should follow general principles that apply to the patient with melanoma as well as to the patient with metastases from other types of primary tumors. When the resection is pa ...
Full textLink to itemCite
Journal ArticleCurr Opin Oncol · March 2002
When deciding to perform a resection for metastatic melanoma one should first decide whether the intent of the procedure is curative or palliative. When the resection is palliative, the success of surgical treatment will depend on the presence of identifia ...
Full textLink to itemCite
Journal ArticleHPB · January 1, 2002
Background: Hepatic encephalopathy is rarely encountered with carcinoid syndrome, but massive hepatic replacement by carcinoid tumour can cause neuropsychiatric alterations. Case outline: A man of 42 years presented with carcinoid syndrome accompanied by f ...
Full textCite
Journal ArticleAnn Surg · January 2002
OBJECTIVE: To analyze a large, single-institution experience with routine frozen section (FS) of the sentinel lymph node (SLN) in patients with primary cutaneous melanoma. SUMMARY BACKGROUND DATA: Controversy exists over the utility of intraoperative FS an ...
Full textLink to itemCite
Journal ArticleCancer · September 15, 2001
BACKGROUND: Immunohistochemical analysis of sentinel lymph nodes from patients with breast carcinoma and melanoma has been shown to increase the sensitivity for detecting lymph node metastases. To the authors' knowledge, this technique has not been describ ...
Full textLink to itemCite
Journal ArticleMol Med · September 1999
BACKGROUND: Costimulatory and cellular adhesion molecules are thought to be essential components of antigen presentation in the immune response to cancer. The current studies examine gene transfer utilizing herpes viral amplicon vectors (HSV) to direct sur ...
Link to itemCite
Journal ArticleSemin Thorac Cardiovasc Surg · July 1999
Desmoid tumors are rare soft tissue neoplasms derived from fascial or musculoaponeurotic structures. These tumors are histologically benign but may behave aggressively at the local level with multiple recurrences after complete resection being common. Ches ...
Full textLink to itemCite
Journal ArticleAnn Surg · January 1999
OBJECTIVES: To characterize the natural history of Merkel cell carcinoma (MCC) and to analyze the influence of patient, tumor, and treatment-related variables on survival and recurrence. SUMMARY BACKGROUND DATA: Approximately 425 cases of MCC have been des ...
Full textLink to itemCite
Journal ArticleJ Surg Res · July 1, 1998
BACKGROUND: The effects of hepatic cryosurgery on residual hepatic tumor growth, and on tumor immunity, have not been determined. MATERIALS AND METHODS: Two experiments were performed. In both, animals (n = 10 per group) had solitary left lobe hepatomas es ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · 1998
BACKGROUND: Surgical resection is the primary treatment for soft tissue sarcoma. Surgeons are in a position to develop and define appropriate treatment strategies for this disease. In an effort to define the contributions of surgeons to the management of s ...
Full textLink to itemCite
ConferenceAm J Surg · August 1997
BACKGROUND: The optimal material for carotid patch angioplasty after endarterectomy remains uncertain. This study compares the early outcome and recurrent stenosis rates between saphenous vein (SV) and expanded polytetrafluoroethylene (ePTFE) carotid patch ...
Full textLink to itemCite
Journal ArticleJ Vasc Surg · August 1995
A case of severe lymphedema of the lower extremity caused by obstruction by human immunodeficiency virus-associated Kaposi's sarcoma is presented. A review of the signs and symptoms of obstructive lymphedema and Kaposi's sarcoma is provided. Early recognit ...
Full textLink to itemCite